<?xml version="1.0"?>
<rdf:RDF xmlns="http://psink.de/scio/"
     xml:base="http://psink.de/scio/"
     xmlns:cc="http://www.oegov.org/models/common/cc#"
     xmlns:scio="http://psink.de/scio/"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:ns="http://creativecommons.org/ns#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:skos="http://www.w3.org/2004/02/skos/core#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:spl="http://spinrdf.org/spl#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:terms="http://purl.org/dc/terms/"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:spin="http://spinrdf.org/spin#"
     xmlns:arg="http://spinrdf.org/arg#"
     xmlns:sp="http://spinrdf.org/sp#"
     xmlns:dc="http://purl.org/dc/elements/1.1/">
    <owl:Ontology rdf:about="http://psink.de/scio/">
        <owl:imports rdf:resource="http://data.qudt.org/qudt/owl/1.0.0/quantity.owl"/>
        <owl:imports rdf:resource="http://data.qudt.org/qudt/owl/1.0.0/unit.owl"/>
        <owl:imports rdf:resource="http://data.qudt.org/qudt/owl/1.0.0/dimension.owl"/>
        <owl:imports rdf:resource="http://www.w3.org/2006/time"/>
        <owl:imports rdf:resource="http://data.qudt.org/qudt/owl/1.0.0/qudt.owl"/>
    </owl:Ontology>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://psink.de/scio/descriptionSource -->

    <owl:AnnotationProperty rdf:about="http://psink.de/scio/descriptionSource">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2000/01/rdf-schema#description"/>
    </owl:AnnotationProperty>
    


    <!-- http://psink.de/scio/example -->

    <owl:AnnotationProperty rdf:about="http://psink.de/scio/example"/>
    


    <!-- http://psink.de/scio/exampleSource -->

    <owl:AnnotationProperty rdf:about="http://psink.de/scio/exampleSource">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/example"/>
    </owl:AnnotationProperty>
    


    <!-- http://psink.de/scio/examplesource -->

    <owl:AnnotationProperty rdf:about="http://psink.de/scio/examplesource"/>
    


    <!-- http://psink.de/scio/relationType -->

    <owl:AnnotationProperty rdf:about="http://psink.de/scio/relationType">
        <rdfs:comment>1:1 &apos;1&apos;
1:n &apos;2&apos;
n:n &apos;3&apos;</rdfs:comment>
    </owl:AnnotationProperty>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#appliedForInjuryType -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#appliedForInjuryType"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#company -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#company"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#description -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#description"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#introduced -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#introduced"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#videoReference -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#videoReference"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#weblink -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#weblink"/>
    


    <!-- http://www.w3.org/2002/07/owl#differentFrom -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2002/07/owl#differentFrom"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://psink.de/scio/litre -->

    <rdfs:Datatype rdf:about="http://psink.de/scio/litre"/>
    

  <!-- http://psink.de/scio/hasName -->

   <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasName">
        <rdfs:domain rdf:resource="http://psink.de/scio/Person"/>
        <rdfs:comment>The name of this person.</rdfs:comment>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has name</rdfs:label>
    </owl:DatatypeProperty>

  <!-- http://psink.de/scio/hasPubmedID -->

   <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasPubmedID">
        <rdfs:domain rdf:resource="http://psink.de/scio/Publication"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>The pubmed id of this publication.</rdfs:comment>
        <rdfs:label>has pubmed id</rdfs:label>
    </owl:DatatypeProperty>

  <!-- http://psink.de/scio/hasPublicationYear -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasPublicationYear">
        <rdfs:domain rdf:resource="http://psink.de/scio/Publication"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>The year of publication.</rdfs:comment>
        <rdfs:label>has publication year</rdfs:label>
    </owl:DatatypeProperty>
    

    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://psink.de/scio/belongsTo -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasTemporalInterval">
        <rdfs:domain rdf:resource="http://psink.de/scio/Observation"/>
        <rdfs:range rdf:resource="http://psink.de/scio/TemporalInterval"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>temporal interval</rdfs:label>
    </owl:ObjectProperty>

    <!-- http://psink.de/scio/belongsTo -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/belongsTo">
        <rdfs:domain rdf:resource="http://psink.de/scio/Observation"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>belongs to</rdfs:label>
    </owl:ObjectProperty>

    <!-- http://psink.de/scio/describes -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/describes">
        <rdfs:domain rdf:resource="http://psink.de/scio/Publication"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Experiment"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>describes</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasAge -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasAge">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/OrganismModel"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Age"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has age</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasAgeCategory -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasAgeCategory">
        <rdfs:domain rdf:resource="http://psink.de/scio/OrganismModel"/>
        <rdfs:range rdf:resource="http://psink.de/scio/AgeCategory"/>
        <example>Three groups of male Sprague-Dawley rats, including young (40 days), mature (5-6 months) and old (28-29 months) were spinally hemisected at the L1 level.</example>
        <exampleSource>PMID: 26024702</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the animal type. Points at the animal age. Age of the animal at time of injury, young or adult or aged.</rdfs:comment>
        <rdfs:description>Specific age stated in days weeks, months or years.</rdfs:description>
        <rdfs:label>has age category</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasAnimalCareCondition -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasAnimalCareCondition">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/AnimalCareCondition"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has animal care condition</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasApplicationInstrument -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasApplicationInstrument">
        <rdfs:domain rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <example>...physiological saline for the vehicle-treated group was administered by an intraperitoneal injection using a syringe immediately after trauma.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the treatment type. Points at the application instrument. This is the instrument for application of therapy or anaesthesia, e.g. syringe, capsule, but also hypothermia blanked, electrodes etc.</rdfs:comment>
        <rdfs:label>has application instrument</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasAuthor -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasAuthor">
        <rdfs:domain rdf:resource="http://psink.de/scio/Publication"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Person"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has author</rdfs:label>
    </owl:ObjectProperty>
    
    <!-- http://psink.de/scio/hasCompositeCompound -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasSuppliedCompositeCompound">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasSuppliedCompound"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/CompoundTreatment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/SuppliedCompound"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:comment>Some combinatorial approaches consist of indivisible units like Schwann cell seeded guidance channels which are implanted as one unit. In order to model this approach, the property &quot;has composite compound&quot; is used.</rdfs:comment>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasSuppliedCompound -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasSuppliedCompound">
        <rdfs:domain rdf:resource="http://psink.de/scio/CompoundTreatment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/SuppliedCompound"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>A compound treatment has usually one compound and this is characterized by its type, dosage, anatomical location and instrument of application. 

If an experimental group is treated with a combinatorial approach as implantation of a cell and injection of a substance, then 2 treatments are associated with this experimental group.

Multiple timepoints can be assigned as treatment timepoint for one treatment, if the other properties of the treatment stay the same, i.e. dosage, delivery method, anatomical location and instrument of application. 
If one or more of these properties are changed, e.g. different doses of a substance are applied at different timepoints, then these paradigms are modeled as individual treatments. This means, dosage X at day 1 is treatment 1, dosage Y at day 2 is treatment 2.

Some combinatorial approaches consist of indivisible units like Schwann cell seeded guidance channels which are implanted as one unit. In order to model this approach, the property &quot;has composite compound&quot; is used.</rdfs:comment>
        <rdfs:label>has compound</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasCompoundBiologicalRelation -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasCompoundBiologicalRelation">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/Cell"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Tissue"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/CompoundBiologicalRelation"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>A cell or tissue implant is defined by its origin as refered to the host organism.</rdfs:description>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasConstraint -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasConstraint">
        <rdfs:domain rdf:resource="http://psink.de/scio/AnalyzedExperimentalGroup"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Constraint"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:description>A constraint defines the property/properties the organisms of an analyzed experimental group have which makes them different from the total population of the experimental group.</rdfs:description>
        <rdfs:label>has constraint</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasCurrent -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasCurrent">
        <rdfs:domain rdf:resource="http://psink.de/scio/ElectromagneticField"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Current"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasDeliveryMethod -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasDeliveryMethod">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/MedicationDuringSurgery"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Treatment"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <example>...physiological saline for the vehicle-treated group was administered by an intraperitoneal injection using a syringe immediately after trauma.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of anaesthetic and compound. Points at the supporting class &quot;Delivery&quot;. This is the route of administration of medication or other substances (e.g. oral, subcutaneous).</rdfs:comment>
        <rdfs:description>Route of administration of medication, cells implants or other therapeutical substances.</rdfs:description>
        <rdfs:label>has delivery method</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasDepth -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasDepth">
        <rdfs:domain rdf:resource="http://psink.de/scio/AnatomicalLocation"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Depth"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Depth is the distance from the dorsal surface of the spinal cord in ventral direction if a substance is injected locally (or a implant is placed).

Some treatment paradigms consist of multiple injections at different depths in the spinal cord. These single injections are not considered single treatments. In order to model these the object property &quot;hasCompositeCompound&quot; is used where multiple application protocols with the same substance can be merged to a &quot;composite compound&quot; treatment.</rdfs:comment>
        <rdfs:label>has depth</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasDirection -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasDirection">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/InclinedPlaneTest"/>
                    <rdf:Description rdf:about="http://psink.de/scio/LateralHemisection"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/Direction"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasDistance -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasDistance">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/AnatomicalLocation"/>
                    <rdf:Description rdf:about="http://psink.de/scio/WeightDrop"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/Distance"/>
        <example>The intact T10 spinal cord was contused with the NYU weight-drop device (from a height of 50 mm).</example>
        <exampleSource>doi: 10.1111/cns.12429</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Distance describes the physical distance of a weight in a weight drop device with respect to the spinal cord surface and also - in the context of a treatment locus - the distance of the application points in relation to a reference point. Thid can be e.g. 1 mm dorsal from the lesion epicenter. 

Some treatment paradigms consist of multiple injections at different locations in the spinal cord. These single injections are not considered single treatments. In order to model these the object property &quot;hasCompositeCompound&quot; is used where multiple application protocols with the same substance can be merged to a &quot;composite compound&quot; treatment.</rdfs:comment>
        <rdfs:description>Measure of spatial distance in µm, mm, cm or other units.</rdfs:description>
        <rdfs:label>has distance</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasDosage -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasDosage">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/Anaesthetic"/>
                    <rdf:Description rdf:about="http://psink.de/scio/CompoundTreatment"/>
                    <rdf:Description rdf:about="http://psink.de/scio/PostsurgicalMedication"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/Dosage"/>
        <example>For alginate-hydrogel (ALG) preparation, a 2% (w/v) solution of alginate (Pronova UP LVM; NovaMatrix) in 150 mM sodium chloride (NaCl) was filtered with a sterile syringe filter.</example>
        <exampleSource>doi:10.1016/j.nbd.2014.03.018</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of anaesthetic, postsurgical medication and compound. Points at supporting class &quot;Dosage&quot;. Information about concentration of a substance or solution of e.g. cells. It can apply for a treatment substance or an anaesthetic or even an outcome measure if e.g. body fluid is investigated.</rdfs:comment>
        <rdfs:label>has dosage</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasDuration -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasDuration">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/FunctionalTest"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Treatment"/>
                    <rdf:Description rdf:about="http://psink.de/scio/WeightDrop"/>
                    <rdf:Description rdf:about="http://psink.de/scio/TemporalInterval"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/Duration"/>
        <example>A weight of 50 g was applied statically to the T9 of spinal cord for 5 min.</example>
        <exampleSource>DOI 10.1007/s12031-015-0564-z</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>Timing of injury process, i.e. if compression is applied for several seconds.</rdfs:description>
        <rdfs:label>has duration</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasElectricFieldStrength -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasElectricFieldStrength">
        <rdfs:domain rdf:resource="http://psink.de/scio/ElectromagneticField"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ElectricFieldStrength"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasEventAfter -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasEventAfter">
        <rdfs:domain rdf:resource="http://psink.de/scio/TemporalInterval"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Event"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has event after</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasEventBefore -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasEventBefore">
        <rdfs:domain rdf:resource="http://psink.de/scio/TemporalInterval"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Event"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has event before</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasExperimentalMethod -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasExperimentalMethod">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Experiment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ExperimentalMethod"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has experimental method</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasExperimentalProcedure -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasExperimentalProcedure">
        <rdfs:domain rdf:resource="http://psink.de/scio/Cell"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ExperimentalProcedure"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:description>Mulitple processing steps can be necessary before a cell or tissue can be implanted.</rdfs:description>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasForce -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasForce">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/Balloon"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Clip"/>
                    <rdf:Description rdf:about="http://psink.de/scio/WeightDrop"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/Force"/>
        <example>In order to induce SCI, a standard weight-drop method that induced a moderately severe injury (100 g/cm force) at T10 was used.</example>
        <exampleSource>doi: 10.1016/j.jss.2013.02.016</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>Pertains to the force of e.g. a clip device or an impactor for spinal cord injury or a measured force in a behavioural test.</rdfs:description>
        <rdfs:label>has force</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasGender -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasGender">
        <rdfs:domain rdf:resource="http://psink.de/scio/OrganismModel"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Gender"/>
        <example>Adult male Wistar albino rats weighing 200–250 g were used in this study.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the animal type. Points at the animal gender. It can be female, male or mixed gender group of animals.</rdfs:comment>
        <rdfs:label>has gender</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasHypothesis -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasHypothesis">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Experiment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Hypothesis"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has hypothesis</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryAnaesthesia -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryAnaesthesia">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>The animals were anesthetized by an intraperitoneal (ip) injection of 10 mg/kg xylasine (Bayer Birlesik Alman _Ilac¸ Fabrikalari T.A.S., Istanbul, Turkey) and 50 mg/kg ketamine hydrochloride (Parke Davis, _Istanbul, Turkey).</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:comment>Property of injury type. Points at anaesthetic. Type of anasthaesia during spinal cord injury surgery. Given before any procedure is carried out.</rdfs:comment>
        <rdfs:label>has injury anaesthesia</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryDevice -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryDevice">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <example>&quot;The rat was then secured to the platform of the IH Impactor
(Precision Systems Instrumentation, Fairfax, VA) using toothed forceps secured to the vertebral elements......Extradural compression of the spinal cord at the vertebral level of T3/4 was achieved using a modified aneurysm clip.&quot;</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of injury type. Points at injury device. Apparatus or instrument used for spinal cord injury.</rdfs:comment>
        <rdfs:label>has injury device</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryLocation -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryLocation">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/VertebralLocation"/>
        <example>Spinal cord injury was carried out in the mid thoracic region at levels T6-T9.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of injury type. Points at injury height and injury height detail. Refers to the anatomical region of the spinal cord. For example cervical, thoracic, lumbar etc. .</rdfs:comment>
        <rdfs:label>has injury height</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryIntensity -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryIntensity">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/InjuryIntensity"/>
        <example>Extradural compression of the spinal cord at the vertebral level of T3/4 was achieved using a modified aneurysm clip (Joshi and Fehlings, 2002a) with a closing force of 8 g producing mechanical trauma of moderate intensity. The clip was left in place for 1 min and then removed.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the injury type. Points at the injury intensity class. The severity of the spinal cord lesion as mentioned by the author, i.e. usually mild, moderate or severe. Also applies for other mentions used by the author as &quot;medium&quot; or &quot;light&quot;.</rdfs:comment>
        <rdfs:label>has injury intensity</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryArea -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryArea">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>The entire right side of the cord was severed from the midline to the far right border of the cord forming a rostral and caudal segment.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the injury. Points at the injury area. Refers to the anatomical region of the lesion inside of the spinal cord. This property points at the injury area, which can be &quot;dorsal&quot;, &quot;ventral&quot;, &quot;complete&quot; etc.</rdfs:comment>
        <rdfs:label>has injury location</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryModel -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryModel">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <rdfs:range>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/Injury"/>
                    <rdf:Description rdf:about="http://psink.de/scio/InjuryByAccident"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:range>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has injury model</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryPostsurgicalCare -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryPostsurgicalCare">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/AnimalCareCondition"/>
        <example>&quot;Post-operative care procedures involved providing the
mice with drinking water in the cage as well as both softened
rat chow and regular pellets placed directly in the cage.
Manual expression of the bladder was also required twice
daily. In total, 124 mice were used. Of these, 51 animals were
kept throughout the survival period in the non-temperature
controlled environment, and 73 in the temperature controlled
environment.&quot;</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:comment>Property of injury type. Points at the class postsurgical care. Any treatment given to the animal immedialtely after surgery to insure its survival and compliance.</rdfs:comment>
        <rdfs:label>has injury postsurgical care</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInjuryType -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInjuryType">
        <rdfs:domain rdf:resource="http://psink.de/scio/InjuryByAccident"/>
        <rdfs:range>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/CompleteTransection"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Compression"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Contusion"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Dislocation"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Distraction"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Laminectomy"/>
                    <rdf:Description rdf:about="http://psink.de/scio/PartialTransection"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:range>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:description>The &quot;has injury type&quot; property links the &quot;Injury by Accident&quot; class with the injury type. In uncontrolled situations there is usually a mix of crush, dislocation and transection of the spinal cord by e.g. bone parts. Therefore multiple injury types must be considered when describing an uncontrolled spinal cord injury situation.</rdfs:description>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasInvestigationMethod -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasInvestigationMethod">
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/InvestigationMethod"/>
        <example>For behavioral testing, we used a ‘motor function scale’18 that is a slight modification of the ‘motor score’ of Gale et al.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the result (trend). It points at the &quot;Investigation Method Type&quot;, which is the laboratory test or experimental method used to investigate the effect of a treatment after spinal cord injury.</rdfs:comment>
        <rdfs:label>has investigation method</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasJudgement -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasJudgement">
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Judgement"/>
        <example>&quot;Some improvements were noted in the vehicle-treated mice over the
next week, which then plateaued; however, minocyclinetreated
mice continued to show improvements in hindlimb
function throughout the survival period.&quot;</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the result, which can be a &quot;positive&quot; or a &quot;negative&quot; effect of a treatment, as stated by author, or &quot;no effect&quot;, which means that no difference between groups was observed.</rdfs:comment>
        <rdfs:label>has judgement</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasLongitude -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasLongitude">
        <rdfs:domain rdf:resource="http://psink.de/scio/Blade"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Longitude"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>The physical dimension of a blade as an injury device.</rdfs:comment>
        <rdfs:label>has longitude</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasLowerVertebrae -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasLowerVertebrae">
        <rdfs:domain rdf:resource="http://psink.de/scio/VertebralArea"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Vertebrae"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has lower vertebrae</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMaximumAge -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMaximumAge">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasAge"/>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMaximumTemperature -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMaximumTemperature">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasTemperature"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMaximumWeight -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMaximumWeight">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasWeight"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMedication -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMedication">
        <rdfs:domain rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:range rdf:resource="http://psink.de/scio/MedicationDuringSurgery"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has medication</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMember -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMember">
        <rdfs:domain rdf:resource="http://psink.de/scio/AnalyzedExperimentalGroup"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has member</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMinimumAge -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMinimumAge">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasAge"/>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMinimumTemperature -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMinimumTemperature">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasTemperature"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasMinimumWeight -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasMinimumWeight">
        <rdfs:subPropertyOf rdf:resource="http://psink.de/scio/hasWeight"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasNumericValue -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasNumericValue">
        <rdfs:domain rdf:resource="http://psink.de/scio/Observation"/>
        <rdfs:range rdf:resource="http://psink.de/scio/NumericValue"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>The observation has a quantified numeric value as outcome.</rdfs:description>
        <rdfs:label>has numeric value</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasObservation -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasObservation">
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Observation"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has observation</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasOrganismModel -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasOrganismModel">
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <rdfs:range rdf:resource="http://psink.de/scio/OrganismModel"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has organism model</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasPressure -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasPressure">
        <rdfs:domain rdf:resource="http://psink.de/scio/Balloon"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Pressure"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has pressure</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasRandomization -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasRandomization">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Experiment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Randomization"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has randomization</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasReferenceGroup -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasReferenceGroup">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <example>The locomotor recovery for the 5-infusion group was significantly greater than for the SALINE GROUP ( p&lt;0.0001) and the 2-INFUSION GROUP ( p&lt;0.0056).</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>A result is obtained from the comparison of two groups, usually the treated and the control group. The reference setup represents the group, which is used for comparison to a target group of interest.</rdfs:description>
        <rdfs:label>has reference group</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasResult -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasResult">
        <rdfs:domain rdf:resource="http://psink.de/scio/Experiment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Result"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has result</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasSignificance -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasSignificance">
        <rdfs:domain rdf:resource="http://psink.de/scio/Trend"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Significance"/>
        <example>As shown in Figure 1A, female animals treated with E2 were significantly better compared to vehicletreated females at day 7 (p less than 0.5) post-injury, but this difference did not persist.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the result. It points at the significance information for a result which can be &quot;yes&quot; or &quot;no&quot;.</rdfs:comment>
        <rdfs:label>has significance</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasSpecies -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasSpecies">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/OrganismModel"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Cell"/>
                    <rdf:Description rdf:about="http://psink.de/scio/Tissue"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/OrganismSpecies"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has species</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasStatisticalTest -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasStatisticalTest">
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/StatisticalTest"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has statistical test</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasStemCellSourceType -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasStemCellSourceType">
        <rdfs:domain rdf:resource="http://psink.de/scio/StemCell"/>
        <rdfs:range rdf:resource="http://psink.de/scio/StemCellSourceType"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    

    <!-- http://psink.de/scio/hasStudyDesign -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasStudyDesign">
        <rdfs:domain rdf:resource="http://psink.de/scio/Experiment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/StudyDesign"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasSupplier -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasSupplier">
        <rdfs:domain rdf:resource="http://psink.de/scio/SuppliedCompound"/>
        <rdfs:range rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <example>All compunds were provided by Dragon Pharmaceuticals.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the compound, e.g. the substance applied. It points at the supplier, e.g. a pharmacological company.</rdfs:comment>
        <rdfs:label>has supplier</rdfs:label>
    </owl:ObjectProperty>
    
    <!-- http://psink.de/scio/hasCompound -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasCompound">
        <rdfs:domain rdf:resource="http://psink.de/scio/SuppliedCompound"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Compound"/>
        <rdfs:label>has compound</rdfs:label>
    </owl:ObjectProperty>


    <!-- http://psink.de/scio/hasTargetGroup -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasTargetGroup">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <example>The locomotor recovery for the 5-INFUSION GROUP was significantly greater than for the saline group ( p&lt;0.0001) and the 2-infusion group ( p&lt;0.0056).</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>A result is obtained from the comparison of two groups, usually the treated and the control group. The target setup represents the focus group, which is compared to a reference group.</rdfs:description>
        <rdfs:label>has target group</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasTemperature -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasTemperature">
        <rdfs:domain rdf:resource="http://psink.de/scio/TemperatureTreatment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Temperature"/>
        <example>&quot;The core temperature as recorded in the esophagus was reduced
from 38° to 30 °C by wetting the animals with a 20% ethanol/water
solution in room temperature (20 °C).&quot;</example>
        <example>An epidural perfusion device was applied to maintain a steady temperature (18 °C) for 120 min with gradual rewarming to 37 °C</example>
        <exampleSource>PMID: 26322652</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the specific class &quot;Physical&quot; treatment with &quot;Temperature&quot;. This points at &quot;degree temperature&quot;.</rdfs:comment>
        <rdfs:description>Temperature, unit is Celsius or Fahrenheit.</rdfs:description>
        <rdfs:label>has temperature</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasThickness -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasThickness">
        <rdfs:domain rdf:resource="http://psink.de/scio/Blade"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Thickness"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has thickness</rdfs:label>
    </owl:ObjectProperty>
    




    <!-- http://psink.de/scio/hasTreatmentLocation -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasTreatmentLocation">
        <rdfs:domain rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Location"/>
        <example>...physiological saline for the vehicle-treated group was administered by an intraperitoneal injection using a syringe immediately after trauma.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the treatment categories &quot;Physical&quot; and &quot;Compound&quot;. Points at the class &quot;treatment location&quot; which refers to local injection, infusion or implantation of a therapeutic or, in case of a systemic treatment, to the route of delivery which can be e.g. &quot;oral&quot;, &quot; intraperitoneal&quot; etc.</rdfs:comment>
        <rdfs:label>has treatment location</rdfs:label>
    </owl:ObjectProperty>
    

    <!-- http://psink.de/scio/hasLocation -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasLocation">
        <rdfs:domain rdf:resource="http://psink.de/scio/NonFunctionalTest"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Location"/>
        <example>Lesion areas from sections containing the central canal were outlined using Image Pro software and lesion size calculated for statistical analysis.</example>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:comment>Property of the investigation method type &quot;non-functional&quot; test. This points at the anatomical location of the tissue investigated in the test, e.g. if a histological method is applied.

Multiple anatomical locations can be used for investigation and pooled in the outcome  measure of an experiment, e.g. if tissue from thoracic level 3, 4 and 5 are used for axon quantification.</rdfs:comment>
        <rdfs:label>has anatomical location</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasTreatmentType -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasTreatmentType">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Treatment"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>has treatment type</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasTrend -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasTrend">
        <rdfs:domain rdf:resource="http://psink.de/scio/Result"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Trend"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has trend</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasUpperVertebrae -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasUpperVertebrae">
        <rdfs:domain rdf:resource="http://psink.de/scio/VertebralArea"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Vertebrae"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has upper vertebrae</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasVoltage -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasVoltage">
        <rdfs:domain rdf:resource="http://psink.de/scio/ElectromagneticField"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Voltage"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasVolume -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasVolume">
        <rdfs:domain rdf:resource="http://psink.de/scio/Balloon"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Volume"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:label>has volume</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/hasWeight -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/hasWeight">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://psink.de/scio/Clip"/>
                    <rdf:Description rdf:about="http://psink.de/scio/OrganismModel"/>
                    <rdf:Description rdf:about="http://psink.de/scio/WeightDrop"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://psink.de/scio/Weight"/>
        <example>After laminectomy, the vertebral column was stabilized with clamps and a 10 g rod was dropped from a 12.5 mm height over the exposed spinal cord and the compression maintained for 5 seconds.</example>
        <exampleSource>PMID: 26896212</exampleSource>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:comment>Property of the animal or of an injury device detail. Points at the supporting class &quot;weight&quot; which can be in g, mg etc.</rdfs:comment>
        <rdfs:description>Any weight measured in µg, g or other units.</rdfs:description>
        <rdfs:label>has weight</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/makesUseOf -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/makesUseOf">
        <rdfs:domain rdf:resource="http://psink.de/scio/InvestigationMethod"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Apparatus"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:description>This property relates the investigation method to the experimental apparatus used.</rdfs:description>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/relativeTo -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/relativeTo">
        <rdfs:domain rdf:resource="http://psink.de/scio/Direction"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Location"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
    </owl:ObjectProperty>
    


    <!-- http://psink.de/scio/testsFor -->

    <owl:ObjectProperty rdf:about="http://psink.de/scio/testsFor">
        <rdfs:domain rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <rdfs:range rdf:resource="http://psink.de/scio/Function"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:label>tests for</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Data properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://psink.de/scio/hasAlphaSignificanceNiveau -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasAlphaSignificanceNiveau">
        <rdfs:domain rdf:resource="http://psink.de/scio/Significance"/>
        <rdfs:label>has alpha significance  niveau</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasFrequency -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasFrequency">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#FunctionalProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:comment>Frequency is the number of ocurrences of a repeating event per unit time. For example, &quot;every 12 hours for one week&quot;. Frequency refers to &quot;every 12 hours&quot;.</rdfs:comment>
        <rdfs:label>has frequency</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasGroupName -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasGroupName">
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:description>Experimental groups are often described with synonyms in a scientific text, e.g. control group (&apos;control&apos;) versus treated group (&apos;treated&apos;).</rdfs:description>
        <rdfs:label>has group name</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasGroupNumber -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasGroupNumber">
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</relationType>
        <rdfs:description>Experimental groups are often described with numbers in a scientific text, e.g. control group (group 1) versus treated group (group 2).</rdfs:description>
        <rdfs:label>has group number</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasInterval -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasInterval">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#FunctionalProperty"/>
        <rdfs:domain rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:comment>The interval refers to a definite length of time marked off by two instances. For example, &quot;every 12 hours for one week&quot;. Interval refers to &quot;one week&quot;.</rdfs:comment>
        <rdfs:label>has interval</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasNNumber -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasNNumber">
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <example>Both animal groups (“TX” vs. “PEG”) initially consisted of N = 14 rats each.</example>
        <exampleSource>doi:10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:description>Integer representing the number of animals per group, per result or per statistical analysis.</rdfs:description>
        <rdfs:label>has N number</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasNonNumericValue -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasNonNumericValue">
        <rdfs:domain rdf:resource="http://psink.de/scio/Observation"/>
        <rdfs:label>has non numeric value</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasPValue -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasPValue">
        <rdfs:domain rdf:resource="http://psink.de/scio/Significance"/>
        <example>Significantly increased numbers of both TH-positive and 5-HT-positive axon profiles were detected in PEG-treated animals compared to TX only-controls (J, mean + SEM, one-sided Mann–Whitney U test; ***p ≤ 0.001).</example>
        <exampleSource>doi:10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:comment>Property of the &quot;significance&quot; of a result which can be either &quot;yes&quot; or &quot;no&quot;. This property points at the p value which was calculated by the author or the p value range for the statistical significance test, e.g. p&lt;0.05.</rdfs:comment>
        <rdfs:description>The P value, or calculated probability, is the probability of finding the observed, or more extreme, results when the null hypothesis (H0) of a study question is true – the definition of ‘extreme’ depends on how the hypothesis is being tested. P is also described in terms of rejecting H0 when it is actually true, however, it is not a direct probability of this state.</rdfs:description>
        <rdfs:label>has p value</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasStandardDeviation -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasStandardDeviation">
        <rdfs:domain rdf:resource="http://psink.de/scio/NumericValue"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=standard+deviation</descriptionSource>
        <rdfs:description>Property of the

Normal Distribution

Continuous frequency distribution of infinite range. Its properties are as follows: 1, continuous, symmetrical distribution with both tails extending to infinity; 2, arithmetic mean, mode, and median identical; and 3, shape completely determined by the mean and standard deviation.</rdfs:description>
        <rdfs:label>has standard deviation</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasStandardError -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasStandardError">
        <rdfs:domain rdf:resource="http://psink.de/scio/NumericValue"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=standard+deviation</descriptionSource>
        <rdfs:description>Property of the

Normal Distribution

Continuous frequency distribution of infinite range. Its properties are as follows: 1, continuous, symmetrical distribution with both tails extending to infinity; 2, arithmetic mean, mode, and median identical; and 3, shape completely determined by the mean and standard deviation.</rdfs:description>
        <rdfs:label>has standard error</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasTotalPopulationSize -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasTotalPopulationSize">
        <rdfs:domain rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <rdfs:label>has total population size</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- http://psink.de/scio/hasZeroSignificance -->

    <owl:DatatypeProperty rdf:about="http://psink.de/scio/hasZeroSignificance">
        <example>The mortality rates were, respectively, 5.55 % (2/36) and 13.9 % (5/36) in groups C and D, and there was no significant difference between groups C and D (P = 0.214).</example>
        <examplesource>doi: 10.1186/s13018-016-0369-y</examplesource>
        <rdfs:description>The result is not statistically significant if a statistical test was performed to test a hypothesis and a certain p value was not reached.</rdfs:description>
        <rdfs:label>has zero significance</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://psink.de/scio/AdhesiveRemovalTest -->

    <owl:Class rdf:about="http://psink.de/scio/AdhesiveRemovalTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SensoryTest"/>
        <descriptionSource>Modified from  doi: 10.1038/nprot.2009.125.</descriptionSource>
        <example>Animals were first tested to indicate the presence of a somatosensory asymmetry. This was done by removing the animal from the home cage for the attachment of adhesive stimuli (Avery adhesive backed labels, 113 mm2) to the distal–radial aspect of both forelimbs.</example>
        <exampleSource>doi:10.1016/S0028-3908(00)00005-8</exampleSource>
        <rdfs:description>Tape removal test for measurement of sensory function.  It consists of applying adhesive tape on each forepaw or hindpaw of the animal and measuring the time-to-contact and the time-to-remove them. This behavior implies correct paw and mouth sensitivity (time-to-contact) and correct paw coordination (time-to-remove).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Age -->

    <owl:Class rdf:about="http://psink.de/scio/Age">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
        <example>Three groups of male Sprague-Dawley rats, including young (40 days), mature (5-6 months) and old (28-29 months) were spinally hemisected at the L1 level.</example>
        <exampleSource>PMID: 26024702</exampleSource>
        <rdfs:description>Specific age stated in days weeks, months or years.</rdfs:description>
    </owl:Class>
    
    <!-- http://psink.de/scio/AgeCategory -->

    <owl:Class rdf:about="http://psink.de/scio/AgeCategory">
        <rdfs:description>The age of the subject at time of the spinal cord injury surgery. For example, young, adult, and aged. According to animal species and weight, or as stated in text.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AirGunImpactor -->

   	<owl:NamedIndividual rdf:about="http://psink.de/scio/AirGunImpactor">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:appliedForInjuryType>Contusion</rdfs:appliedForInjuryType>
        <rdfs:introduced>Title: Air gun impactor--a novel model of graded white matter spinal cord injury in rodents.
Year: 2012
Species: Rat.
DOI: 10.1055/s-0032-1315779</rdfs:introduced>
    </owl:NamedIndividual>
    

    <!-- http://psink.de/scio/AllenWeightDropDevice -->

    <owl:Class rdf:about="http://psink.de/scio/AllenWeightDropDevice">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/WeightDrop"/>
        <example>New Zealand White rabbits sustained SCI or sham injury via the Allen weight-drop technique.</example>
        <exampleSource>PMID: 16506468</exampleSource>
        <rdfs:description>Laboratory device for accurate targeting and weight drop from specified heights in order to produce  traumatic brain or spinal cord injury.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Allodynia -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Allodynia">
        <rdf:type rdf:resource="http://psink.de/scio/SensoryFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Anaesthetic -->

    <owl:Class rdf:about="http://psink.de/scio/Anaesthetic">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicationDuringSurgery"/>
        <rdfs:description>Type of anasthaesia applied during spinal cord injury surgery.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AnalyzedExperimentalGroup -->

    <owl:Class rdf:about="http://psink.de/scio/AnalyzedExperimentalGroup">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
        <rdfs:description>The subgroup of an experimental group which is analyzed in the experiment.</rdfs:description>
    </owl:Class>
    
 <!-- http://psink.de/scio/Location -->

    <owl:Class rdf:about="http://psink.de/scio/Location"/>


    <!-- http://psink.de/scio/AnatomicalLocation -->

    <owl:Class rdf:about="http://psink.de/scio/AnatomicalLocation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Location"/>
        <example>The spinal cord was prepared for tissue evaluation in week 8.</example>
        <exampleSource>DOI: 10.1186/s13287-016-0295-2</exampleSource>
        <rdfs:description>Refers to the exact anatomical region where a test is conducted or tissue is taken from.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AneuyrismClip -->

    <owl:Class rdf:about="http://psink.de/scio/AneuyrismClip">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Clip"/>
        <example>The spinal cord was injured by cord compression with a 24 g modified aneurysm clip for 1 min, resulting in a moderate SCI.</example>
        <exampleSource>doi:10.1016/j.biomaterials.2015.12.032</exampleSource>
        <rdfs:appliedForInjuryType>Compression</rdfs:appliedForInjuryType>
        <rdfs:description>Aneurysm clip is a surgical instrument used to treat a balloon-like bulge of an artery wall known as an aneurysm. In experimental spinal cord injury studies these clips are used to inflict compression lesions to the spinal cord.</rdfs:description>
        <rdfs:introduced>Title: Clip compression model is useful for thoracic spinal cord injuries: histologic and functional correlates.
DOI: 10.1097/BRS.0b013e31815b7e6b
Year: 2007
Species: Rat</rdfs:introduced>
        <rdfs:videoReference>Jove DOI:10.3791/50149
Jove Title: A Novel Vertebral Stabilization Method for Producing Contusive Spinal Cord Injury.
Jove Year: 2015
Species: Rat</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/AngiogenesisTest -->

    <owl:Class rdf:about="http://psink.de/scio/AngiogenesisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonNeuronalCellChangesTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68018919</descriptionSource>
        <example>In this study, we found that increased levels of miR-126 promoted angiogenesis, and inhibited leukocyte extravasation into the injured spinal cord, which was concurrent with downregulation of mRNA and protein expression of three validated miR-126 target genes, SPRED1, PIK3R2, and VCAM1.</example>
        <rdfs:description>The development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AnimalCareCondition -->

    <owl:Class rdf:about="http://psink.de/scio/AnimalCareCondition">
        <rdfs:description>Depending on the severity of the injury, medication and special care like e.g. manual bladder voiding is necessary in the postsurgical phase.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AnimalModel -->

	 <owl:Class rdf:about="http://psink.de/scio/AnimalModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/AnimalSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/OrganismModel"/>
        <rdfs:description>Animal model used in the experimental study.</rdfs:description>
        <rdfs:comment>Aggregation class for properties of the animal model, like animal age, gender etc.</rdfs:comment>
    </owl:Class>
    


    <!-- http://psink.de/scio/AnimalSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/OrganismSpecies"/>
     
	<!-- http://psink.de/scio/AnimalSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/AnimalSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/OrganismSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Antibody -->

    <owl:Class rdf:about="http://psink.de/scio/Antibody">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Protein"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007136</descriptionSource>
        <rdfs:description>Immunoglobulins

Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ApoptosisTest -->
    
    <owl:Class rdf:about="http://psink.de/scio/ApoptosisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68017209</descriptionSource>
        <example>In addition, neuronal apoptosis was detected 24 hr after injury followed by a profound increase
in ED1-positive inflammatory infiltrates, glial fibrillary acidic protein (GFAP)-positive reactive astrocytes,
and oligodendrocyte apoptosis by 1 week after SCI relative to control.</example>
        <rdfs:description>Investigation of apoptosis as a part of secondary degeneration.

One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.</rdfs:description>
    </owl:Class>


    <!-- http://psink.de/scio/Apparatus -->

    <owl:Class rdf:about="http://psink.de/scio/Apparatus"/>
    


    <!-- http://psink.de/scio/ApplicationInstrument -->

    <owl:Class rdf:about="http://psink.de/scio/ApplicationInstrument">
        <rdfs:description>Instrument for pharmacological treatment administration, i.e. syringe or osmotic minipump.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AstrogliosisTest -->

    <owl:Class rdf:about="http://psink.de/scio/AstrogliosisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonNeuronalCellChangesTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=astrogliosis</descriptionSource>
        <example>Both pioglitazone and rosiglitazone (1.5 mg/kg i.p.; four doses at 5 min and 12, 24, and 48 h) significantly decreased the lesion size (by 57 to 68%, p .&lt;0.05), motor neuron loss (by 3- to 10-fold, p .&lt;0.05), myelin loss (by 66 to 75%, p &lt; 0.05), astrogliosis (by 46 to 61%, p &lt;0.05), and microglial activation (by 59 to 78%, p .&lt;0.05) after SCI.</example>
        <rdfs:description>The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AutomatedGaitAnalysis -->

    <owl:Class rdf:about="http://psink.de/scio/AutomatedGaitAnalysis">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/GaitTest"/>
        <rdfs:description>Gait analysis using automated systems as the CatWalk or DigiGait apparatus.
Measures walking patterns and kinematics either while crossing solid surfaces or treadmills.</rdfs:description>
        <rdfs:videoReference>Jove Title:Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-aged, and Geriatric Rats
Jove Year: 2011
Jove Species: Rat
Jove DOI:10.3791/2138</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/AutonomicDysreflexiaTest -->

    <owl:Class rdf:about="http://psink.de/scio/AutonomicDysreflexiaTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=autonomic+dysreflexia</descriptionSource>
        <example>The maximum voiding pressure and the number of uninhibited contractions were significantly lower in the group treated with intravesical onabotA than in the SCT-only group. Intravesical onabotA significantly blocked the dysreflexia response (high arterial pressure with bradycardia) induced by CMG after SCT.</example>
        <exampleSource>doi: 10.1111/j.1464-410X.2011.010362.x</exampleSource>
        <rdfs:description>A syndrome associated with damage to the spinal cord above the mid thoracic level characterized by a marked increase in the sympathetic response to minor stimuli such as bladder or rectal distention.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AutophagyObservation -->

    <owl:Class rdf:about="http://psink.de/scio/AutophagyObservation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ObservationOfBehaviour"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/AvoidanceResponseTest -->

    <owl:Class rdf:about="http://psink.de/scio/AvoidanceResponseTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PainTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68001362</descriptionSource>
        <example>Likewise, at 6 weeks PEG-, MgSO4-, and saline-treated control animals showed 3.5 +/- 0.4, 2.8 +/- 0.9, and 5.0 +/- 0.5
avoidance responses to at-level touch, respectively.</example>
        <exampleSource>DOI: 10.1002/jnr.21283</exampleSource>
        <rdfs:description>Avoidance Learning
A response to a cue that is instrumental in avoiding a noxious experience</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AxonalChangesTest -->

    <owl:Class rdf:about="http://psink.de/scio/AxonalChangesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeuronalChangesTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/AxonalDamageTest -->

    <owl:Class rdf:about="http://psink.de/scio/AxonalDamageTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AxonalChangesTest"/>
        <rdfs:description>Investigation of axonal damage as measure for failed neuroprotection.</rdfs:description>
        <example>The effect of MEL on axonal damage was also investigated using antibody specific for dephosphorylated neurofilament protein (dNFP).</example>
        <exampleSource>PMID: 18086148</exampleSource>
    </owl:Class>
    


    <!-- http://psink.de/scio/AxonalDiebackTest -->

    <owl:Class rdf:about="http://psink.de/scio/AxonalDiebackTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AxonalChangesTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/AxonalRegenerationTest -->

    <owl:Class rdf:about="http://psink.de/scio/AxonalRegenerationTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AxonalChangesTest"/>
        <example>Even after complete chronic transection, the PEG-bridge allowed long-distance axon regeneration through the grafted area and for, at least, 1cm beyond the lesion/graft border.</example>
        <exampleSource>doi: 10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:description>Investigation of axonal regeneration as neuronal cell change. Usually stated in the text as &quot;axonal regeneration&quot; or &quot;axonal regrowth&quot;. This is in contrast to axon sparing or axon sprouting which could also stand for the growth of unlesioned axons.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/AxonalSproutingTest -->

    <owl:Class rdf:about="http://psink.de/scio/AxonalSproutingTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AxonalChangesTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/BBBSubscoreTest -->

    <owl:Class rdf:about="http://psink.de/scio/BBBSubscoreTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeurologicScalesTest"/>
        <example>We found that neither erythropoietin nor darbepoetin led to improved behavioral recovery over saline controls, with no significant differences observed in BBB scores, BBB subscores, footfall errors on horizontal ladder testing, width of hindlimb base of support, or threshold for paw withdrawal on sensory testing.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2007.12.013</exampleSource>
        <rdfs:description>Subscoring system of the Basso-Beattie-Bresnahan locomotor scale.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/BBBTest -->

    <owl:Class rdf:about="http://psink.de/scio/BBBTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeurologicScalesTest"/>
        <example>At three days following SCI, two investigators blinded to treatment groups assessed open field locomotor functional recovery using the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale</example>
        <exampleSource>doi:  10.1371/journal.pone.0147716</exampleSource>
        <rdfs:description>Scale for locomotion in the rat: Basso-Beattie-Bresnahan locomotor scale. This open field walking score measures recovery of hindlimb movements in rats during free open field locomotion as described by Basso et al.</rdfs:description>
        <rdfs:introduced>Title: A sensitive and reliable locomotor rating scale for open field testing in rats.
Year: 1995
Species: Rat
DOI: 10.1089/neu.1995.12.1</rdfs:introduced>
    </owl:Class>
    


    <!-- http://psink.de/scio/BMSTest -->

    <owl:Class rdf:about="http://psink.de/scio/BMSTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeurologicScalesTest"/>
        <rdfs:description>Basso Mouse Scale
A neurologic scale describing open field locomotion of the mouse after spinal cord contusion.</rdfs:description>
        <rdfs:introduced>Title: Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.
Year: 2006
Species: Mouse
DOI: 10.1089/neu.2006.23.635</rdfs:introduced>
    </owl:Class>
    


    <!-- http://psink.de/scio/BalanceAbility -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/BalanceAbility">
        <rdf:type rdf:resource="http://psink.de/scio/MotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Balloon -->

    <owl:Class rdf:about="http://psink.de/scio/Balloon">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:description>A small balloon is inserted into the epidural space and inflated by saline or air to cause a graded spinal cord injury without damaging surrounding tissue.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Blade -->

    <owl:Class rdf:about="http://psink.de/scio/Blade">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/CuttingDevice"/>
        <example>Half of the spinal cord (left side) was then transected at thoracic position (T) 10 with a razor blade.</example>
        <exampleSource>doi:  10.3390/ijms131013484</exampleSource>
        <rdfs:description>Class of sharp cutting instruments like razor blades, scalpels etc.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/BloodBrainBarrierTest -->

    <owl:Class rdf:about="http://psink.de/scio/BloodBrainBarrierTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68001812</descriptionSource>
        <example>RA attenuated BSCB permeability and decreased the loss of tight junction (TJ) molecules such as P120, β-catenin, Occludin and Claudin5 after injury in vivo as well as in Brain Microvascular Endothelial Cells (BMECs).</example>
        <exampleSource>doi:10.7150/ijbs.13229</exampleSource>
        <rdfs:description>Blood-Brain Barrier

Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/BloodCirculationExamination -->

    <owl:Class rdf:about="http://psink.de/scio/BloodCirculationExamination">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicalExamination"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68001775</descriptionSource>
        <example>SCBF was measured in the ischemic penumbra zone surrounding the trauma epicenter using contrast-enhanced ultrasonography.</example>
        <exampleSource>doi: 10.1007/s00586-013-3086-9</exampleSource>
        <rdfs:description>Blood Circulation
The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/BodyTemperatureMeasurement -->

    <owl:Class rdf:about="http://psink.de/scio/BodyTemperatureMeasurement">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalCareCondition"/>
        <rdfs:description>Measurement of body temperature since this is a marker for the overall health state of the subject.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/BodyWeightExamination -->

    <owl:Class rdf:about="http://psink.de/scio/BodyWeightExamination">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicalExamination"/>
        <example>We examined the changes in body weight, histopathological changes, apoptosis, and the expressions of apoptosis-related proteins after 14 days and 28 days after transplantation.</example>
        <exampleSource>http://dx.doi.org/10.1155/2015/516215</exampleSource>
        <rdfs:description>Record of the animal body weight.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Brain -->

    <owl:Class rdf:about="http://psink.de/scio/Brain">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/CentralNervousSystem"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68001921</descriptionSource>
        <example>Retrograde axonal Fluoro-Gold tracing of pyramidal neurons in
layer V of primary somatosensory cortex projecting into the dorsal CST revealed a remarkable rescue effect of the scar-suppressing treatment in the cortical area of Bregma -1.1 to - 2.1 mm.</example>
        <exampleSource>PMID: 16367771</exampleSource>
        <rdfs:description>The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Capsule -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Capsule">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68002214</descriptionSource>
        <example>Young adult female rats received either sham or T9 spinal cord contusion injuries and were implanted with blank or testosterone-filled Silastic capsules.</example>
        <exampleSource>doi: 10.1002/cne.23066</exampleSource>
        <rdfs:description>Hard or soft soluble containers used for the oral administration of medicine.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/CardioVascularFunctionTest -->

    <owl:Class rdf:about="http://psink.de/scio/CardioVascularFunctionTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=cardiovascular+function</descriptionSource>
        <example>Pretreatment with atropine prevented changes in MAP, HR and NADPH-d staining suggesting that such modifications result from an increased vagal stimulation.</example>
        <exampleSource>DOI: 10.1016/S0304-3940(99)00495-4</exampleSource>
        <rdfs:description>Cardiovascular Physiological Phenomena
Processes and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/CatModel -->

    <owl:Class rdf:about="http://psink.de/scio/CatModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/CatSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68002415</descriptionSource>
        <rdfs:description>The domestic cat, Felis catus, of the carnivore family FELIDAE.</rdfs:description>
    </owl:Class>
    

    <!-- http://psink.de/scio/RabbitModel -->

    <owl:Class rdf:about="http://psink.de/scio/RabbitModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/RabbitSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
    </owl:Class>
    
  <!-- http://psink.de/scio/RabbitSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/RabbitSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    

    <!-- http://psink.de/scio/CatSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/CatSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Catheter -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Catheter">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68057785</descriptionSource>
        <example>Immediately afterwards, the energy substrate acetyl-l-carnitine (ALC; 1 mg/day) or phosphate-buffered saline (PBS) was infused intrathecally (sub-arachnoid) for 6 days via an L5/6 catheter attached to a subcutaneous Alzet pump.</example>
        <exampleSource>doi: 10.1089/neu.2015.4030</exampleSource>
        <rdfs:description>A flexible, tubular device that is used to carry fluids into or from a blood vessel, hollow organ, or body cavity.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Caudal -->

    <owl:Class rdf:about="http://psink.de/scio/Caudal">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Direction"/>
        <example>During the same surgery, a laminectomy of half a
segment was performed at Th7, and a fine catheter (Recathco, LLC, Allison Park, PA) was
inserted sub-durally to a region directly caudal to the lesion site.</example>
        <exampleSource>doi:10.1089/neu.2009.1116</exampleSource>
        <rdfs:description>Application of a treatment caudal to the lesion site.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Cell -->

    <owl:Class rdf:about="http://psink.de/scio/Cell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Compound"/>
        <example>Previous reports from our laboratory have documented the antiinflammatory potential of lovastatin, which was found to block expression of iNOS and proinflammatory cytokines (TNF., IL-1., and IL-6) in activated glial *cells* (microglia and astrocytes) and macrophages in culture (Pahan et al., 1997).</example>
        <rdfs:description>Treatment with cells, e.g. genetically modified cells.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/CentralNervousSystem -->

    <owl:Class rdf:about="http://psink.de/scio/CentralNervousSystem">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnatomicalLocation"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68002490</descriptionSource>
        <example>For analysis of Fluoro-Gold-traced CPCs, brain and thoracic spinal cord were removed and postﬁxed in 4% paraformaldehyde for 24 h, then cryopreserved for 48 h in 30% sucrose.</example>
        <exampleSource>PMID: 16367771</exampleSource>
        <rdfs:description>Central Nervous System
The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/CephalicVeinDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/CephalicVeinDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/IntravenousDelivery"/>
        <example>All injections were given as an intravenous bolus via the cephalic (forearm)
vein.</example>
        <exampleSource>PMID: 6539814</exampleSource>
        <rdfs:description>Forearm vein.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Change -->

    <owl:Class rdf:about="http://psink.de/scio/Change">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Trend"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ChemicalInjury -->

    <owl:Class rdf:about="http://psink.de/scio/ChemicalInjury">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Clip -->

    <owl:Class rdf:about="http://psink.de/scio/Clip">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:description>Surgical instrument used to inflict a compression injury to the spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Complete -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Complete">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>After the dura mater was cut, the spinal cord was incised
about 2 mm from the level of T8 toward caudal end and
completely removed, forming about 2 mm transection gap.</example>
        <exampleSource>DOI 10.1007/s10856-011-4401-9</exampleSource>
        <rdfs:description>Complete cross-area of the spinal cord is lesioned.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/CompleteTransection -->

    <owl:Class rdf:about="http://psink.de/scio/CompleteTransection">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
        <example>Here, we aimed to analyse the changes in the dopaminergic system of the sea lamprey after a complete spinal transection by studying the changes in dopaminergic cell numbers and dopaminergic innervation in the spinal cord.</example>
        <exampleSource>doi: 10.1155/2015/350750</exampleSource>
        <rdfs:description>Complete cross-cut of the spinal cord at a specific height.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Compound -->

    <owl:Class rdf:about="http://psink.de/scio/Compound"/>
    


    <!-- http://psink.de/scio/CompoundBiologicalRelation -->

    <owl:Class rdf:about="http://psink.de/scio/CompoundBiologicalRelation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/CompoundSource"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/CompoundSource -->

    <owl:Class rdf:about="http://psink.de/scio/CompoundSource"/>
    


    <!-- http://psink.de/scio/CompoundSupplier -->

    <owl:Class rdf:about="http://psink.de/scio/CompoundSupplier">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/CompoundSource"/>
        <rdfs:description>Company listing of suppliers for compounds used in the experimental study.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/CompoundTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/CompoundTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:description>Treatment with a compound which can be a substance, cell, implant etc. which is either applied locally or systemically.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Compression -->

    <owl:Class rdf:about="http://psink.de/scio/Compression">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
        <example>We tested our proposal by administering Huperzine A intraperitoneally to male Wistar Albino rats (220-340 gr body weight) after moderate static clip compression (70 gr for 60 sec) of the spinal cord at T7 level.</example>
        <exampleSource>PMID: 26472141</exampleSource>
        <rdfs:description>Compression (or crush) of the spinal cord is naturally caused by bone fragments, tumors or other pathological conditions. In the experimental spinal cord injury model, compression means a constant force being inflicted on the spinal cord from one or multiple sides simultaneously. This is in contrast to contusion, where a short term force is inflicted on the spinal cord from one side.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Conduit -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Conduit">
        <rdf:type rdf:resource="http://psink.de/scio/Compound"/>
        <example>In this study, this bridge is tested, consisting of adult neural stem/progenitor cells contained within a methacrylamide chitosan (MAC) hydrogel and protected by a chitosan conduit.</example>
        <exampleSource>doi: 10.1002/adhm.201500810</exampleSource>
        <rdfs:description>Implantation of conduits which connect seperated spinal cord areas.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Constraint -->

    <owl:Class rdf:about="http://psink.de/scio/Constraint">
        <relationType rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</relationType>
        <rdfs:description>Describes the criteria which define the subset of the analyzed experimental group in comparison to the experimental group.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ContactPlacingResponseTest -->

    <owl:Class rdf:about="http://psink.de/scio/ContactPlacingResponseTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorReflexTest"/>
        <descriptionSource>doi:10.1016/S0006-8993(00)02778-5</descriptionSource>
        <example>Motor function was assessed with the BBB locomotor rating scale and a contact plantar placement task.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2013.12.019</exampleSource>
        <rdfs:description>Motor reflex test as subclass of investigation method/functional test. 
Contact placing is elicited by lightly touching the skin of the dorsal side of the foot without joint displacement. The animal responds by lifting the hind leg and placing it upon the obstacle.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Contusion -->

    <owl:Class rdf:about="http://psink.de/scio/Contusion">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
        <example>Adult female Sprague Dawley rats (~230 g) received a moderate contusion to the thoracic (T9-T10) spinal cord, using the MASCIS impactor device.</example>
        <exampleSource>PMID: 26896212</exampleSource>
        <rdfs:description>Contusion is an experimental spinal cord injury model where force is inflicted on the spinal cord from one side for a short moment.

&quot;Contusion devices are designed to inflict a transient, acute injury to the spinal cord. The category includes weight-drop apparatuses,electromagnetic impactors and a recently described air gun device.&quot;doi:10.1038/sc.2014.91</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Current -->

    <owl:Class rdf:about="http://psink.de/scio/Current">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/CurrentApplication -->

    <owl:Class rdf:about="http://psink.de/scio/CurrentApplication">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ElectromagneticField"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/CuttingDevice -->

    <owl:Class rdf:about="http://psink.de/scio/CuttingDevice">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:description>Instruments with sharp edges to inflict cutting lesions to the spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/CystVolumeTest -->

    <owl:Class rdf:about="http://psink.de/scio/CystVolumeTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
        <rdfs:description>Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.</rdfs:description>
        <example>After nanoparticle delivery twice into each rat, the visualized syringomyelic cyst volume significantly decreased from 5.71±0.21 mm3 to 3.23±0.364 mm3 and to 1.48±0.722 mm3.</example>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68003560</descriptionSource>
        <exampleSource>PMID: 26486048</exampleSource>
    </owl:Class>
    

    <!-- http://psink.de/scio/DNA -->

    <owl:Class rdf:about="http://psink.de/scio/DNA">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NucleicAcid"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004247</descriptionSource>
        <rdfs:description>A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/DefinedExperimentalGroup -->

    <owl:Class rdf:about="http://psink.de/scio/DefinedExperimentalGroup">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/DeliveryMethod -->

    <owl:Class rdf:about="http://psink.de/scio/DeliveryMethod">
        <rdfs:description>Route of administration of medication, cells implants or other therapeutical substances.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Depth -->

    <owl:Class rdf:about="http://psink.de/scio/Depth">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
        <rdfs:description>Describes the depth of the application of a therapeutic substance or implant at the horizontal level. An injection from dorsal to the midline would result in a lesion depth of half the spinal cord&apos;s height. Injection depths are often given in mm.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Direction -->

    <owl:Class rdf:about="http://psink.de/scio/Direction">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SpatialDimensions"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Dislocation -->

    <owl:Class rdf:about="http://psink.de/scio/Dislocation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/DislocationDevice -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/DislocationDevice">
        <rdf:type rdf:resource="http://psink.de/scio/DistractorDevices"/>
        <rdfs:introduced>1.
Title: A vertebral dislocation model of spinal cord injury in rats.
Year: 2004
Species: Rat
DOI : 10.1089/089771504323004593

2.
Title:Modeling spinal cord contusion, dislocation, and distraction: characterization of vertebral clamps, injury severities, and node of Ranvier deformations.
Year: 2009
Species: Rat
DOI: 10.1016/j.jneumeth.2009.04.007</rdfs:introduced>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Distance -->

    <owl:Class rdf:about="http://psink.de/scio/Distance">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
        <rdfs:description>Distance measured in any unit (e.g. µm, mm).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Distraction -->

    <owl:Class rdf:about="http://psink.de/scio/Distraction">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/DistractorDevices -->

    <owl:Class rdf:about="http://psink.de/scio/DistractorDevices">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/DogModel -->

    <owl:Class rdf:about="http://psink.de/scio/DogModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/DogSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004285</descriptionSource>
        <rdfs:description>The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/DogSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/DogSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Dorsal -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Dorsal">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>This study examined the effects of CB2R modulation on the fate of axotomized rubrospinal neurons (RSNs) and functional recovery in a model of spinal cord dorsal hemisection (SCH) at the cervical level in rats.</example>
        <exampleSource>doi: 10.1038/cddis.2014.364</exampleSource>
        <rdfs:description>Lesion of the dorsal half of the spinal cord.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/DorsalHemisection -->

    <owl:Class rdf:about="http://psink.de/scio/DorsalHemisection">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PartialTransection"/>
        <example>As adults, mice received dorsal hemisection injuries at T12 or complete crush injuries at T9.</example>
        <exampleSource>doi: 10.1002/cne.23987</exampleSource>
        <rdfs:description>Dorsal partial transection of the spinal cord, leaving ventral spinal tracts intact.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Dosage -->

    <owl:Class rdf:about="http://psink.de/scio/Dosage">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
        <rdfs:description>Information about concentration of a substance or solution of e.g. cells. It can apply for a treatment substance or an anaesthetic or even an outcome measure if e.g. body fluid is investigated.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/DosageExtracorporal -->

    <owl:Class rdf:about="http://psink.de/scio/DosageExtracorporal">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Dosage"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/DosageIntracorporal -->

    <owl:Class rdf:about="http://psink.de/scio/DosageIntracorporal">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Dosage"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/DoubleBlindStudy -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/DoubleBlindStudy">
        <rdf:type rdf:resource="http://psink.de/scio/ExperimentalMethod"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Duration -->

    <owl:Class rdf:about="http://psink.de/scio/Duration">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ElectricFieldStrength -->

    <owl:Class rdf:about="http://psink.de/scio/ElectricFieldStrength">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Electrodes -->

    <owl:Class rdf:about="http://psink.de/scio/Electrodes">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004567</descriptionSource>
        <example>SCI rats were instrumented with chronic FES electrodes in the hindlimb muscles and were divided into two groups: (a) FES therapy and (b) sedentary.</example>
        <exampleSource>doi: 10.1179/2045772313Y.0000000117</exampleSource>
        <rdfs:description>Surgically placed electric conductors through which ELECTRIC STIMULATION is delivered to or electrical activity is recorded from a specific point inside the body.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ElectromagneticField -->

    <owl:Class rdf:about="http://psink.de/scio/ElectromagneticField">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysicalTreatment"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ElectrophysiologyTest -->

    <owl:Class rdf:about="http://psink.de/scio/ElectrophysiologyTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004594</descriptionSource>
        <example>Accordingly, the activity of the neuronal populations recorded at specific thalamic locations that correspond to the forepaw and hindpaw circuits was recorded under control conditions and immediately after thoracic SCI. The results demonstrate that peripheral inputs from both extremities overlap on neuronal populations in the somatosensory thalamus.</example>
        <exampleSource>PMID: 26706597</exampleSource>
        <rdfs:description>The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/EnrichedEnvironment -->

    <owl:Class rdf:about="http://psink.de/scio/EnrichedEnvironment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/RehabilitativeTraining"/>
        <example>High-Impact, Self-Motivated Training Within an Enriched Environment With Single Animal Tracking Dose-Dependently Promotes Motor Skill Acquisition and Functional Recovery.</example>
        <examplesource>10.1177/1545968314520721</examplesource>
        <rdfs:description>Housing in an enriched environment to increase natural movement of the animals.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Enzyme -->

    <owl:Class rdf:about="http://psink.de/scio/Enzyme">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Protein"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004798</descriptionSource>
        <rdfs:description>Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/EpiduralClip -->

    <owl:Class rdf:about="http://psink.de/scio/EpiduralClip">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Clip"/>
        <example>The spinal cord injury was made at T10 level by the epidural clip compression method.</example>
        <exampleSource>PMID: 8861702</exampleSource>
        <rdfs:description>Surgical instrument used to inflict a compression injury to the spinal cord. The clipping device is not further specified. It is placed epidurally to inflict the spinal cord lesion.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Event -->

    <owl:Class rdf:about="http://psink.de/scio/Event">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2006/time#TemporalEntity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Experiment -->

    <owl:Class rdf:about="http://psink.de/scio/Experiment">
        <rdfs:description>Represents the paradigm in which studies have been carried out.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ExperimentalGroup -->

    <owl:Class rdf:about="http://psink.de/scio/ExperimentalGroup">
        <example>Prior to surgery, rats of the lesioned treated (n = 9, Fig. 7A) and lesioned control groups (n = 7, Fig. 7B) showed a low proportion of irregular walking patterns reaching 2.3 ± 1.0% and 0.7 ± 0.7%, respectively.</example>
        <exampleSource>doi:10.1111/j.1460-9568.2005.04495.x</exampleSource>
        <rdfs:description>This class connects the classes Organism Model, Injury Model, and Treatment Type and Group Names.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ExperimentalMethod -->

    <owl:Class rdf:about="http://psink.de/scio/ExperimentalMethod">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/StudyDesign"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ExperimentalProcedure -->

    <owl:Class rdf:about="http://psink.de/scio/ExperimentalProcedure">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/StudyDesign"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Extremity -->

    <owl:Class rdf:about="http://psink.de/scio/Extremity">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnatomicalLocation"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68005121</descriptionSource>
        <example>The ability for OEG to facilitate regeneration was analyzed electrophysiologically by transcranially stimulating the brainstem and recording motor evoked potentials (MEP) with chronically implanted intramuscular EMG electrodes in the soleus and tibalis anterior with and without intrathecal injections of noradrenergic, serotonergic, and glycinergic receptor antagonists.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2011.01.007</exampleSource>
        <rdfs:description>The target tissue is located in the extremities, i.e. arms, legs (digits, toes etc.).

Extremities
The farthest or outermost projections of the body, such as the HAND and FOOT</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/FemoralVeinDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/FemoralVeinDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/IntravenousDelivery"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68005268</descriptionSource>
        <example>Purified MSC from a human donor were transplanted into the CSF at the lumbar region (LP), into the femoral vein (IV), or directly into the injury (control).</example>
        <exampleSource>doi: 10.1097/BRS.0b013e31819403ce</exampleSource>
        <rdfs:description>The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/FineMotorControlAbility -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/FineMotorControlAbility">
        <rdf:type rdf:resource="http://psink.de/scio/MotorFunction"/>
    </owl:NamedIndividual>
    

    <!-- http://psink.de/scio/FogartyBalloonCatheter -->

    <owl:Class rdf:about="http://psink.de/scio/FogartyBalloonCatheter">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Balloon"/>
        <example>A 2-French Fogarty catheter is inserted into the dorsal epidural space through a small hole made in T10 vertebral arch, advanced cranially to T8-9 spinal level, and inflated for 5 min.</example>
        <exampleSource>PMID: 11780869</exampleSource>
        <rdfs:appliedForInjuryType>Compression</rdfs:appliedForInjuryType>
        <rdfs:company>Edwards</rdfs:company>
        <rdfs:description>The Fogarty catheter is a special balloon catheter device to induce compression injury.</rdfs:description>
        <rdfs:introduced>Title: A Simple and Reproducible Model of Spinal Cord Injury Induced by Epidural Balloon Inflation in the Rat
Year: 2004
Spcies: Rat
DOI: 10.1089/08977150152725687</rdfs:introduced>
        <rdfs:weblink>http://www.edwards.com/de/products/vascular/clotmanagement/Pages/arterialmodels.aspx</rdfs:weblink>
    </owl:Class>
    


    <!-- http://psink.de/scio/FootprintAnalysisTest -->

    <owl:Class rdf:about="http://psink.de/scio/FootprintAnalysisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/LocomotorTest"/>
        <example>Footprint analysis revealed improved functional outcome after minocycline treatment.</example>
        <exampleSource>PMID: 14999069</exampleSource>
        <rdfs:description>Analysis of the footprints of the animals walking.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Force -->

    <owl:Class rdf:about="http://psink.de/scio/Force">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Forceps -->

    <owl:Class rdf:about="http://psink.de/scio/Forceps">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:appliedForInjuryType>Compression</rdfs:appliedForInjuryType>
        <rdfs:description>Surgical instruments used in experimental spinal cord injury studies to crush the spinal cord by applying constant force from two sides for a specified duration.</rdfs:description>
        <rdfs:introduced>Title: Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology.
Year: 1991
Species: Guinea Pig
PMID: PMID 1880533</rdfs:introduced>
        <rdfs:videoReference>1.
Jove DOI: 10.3791/53498
Jove Title: A Neonatal Mouse Spinal Cord Compression Injury Model
Jove Year: 2016
Jove Species: Mouse

2.
Jove DOI: 10.3791/52318
Jove Title: Calibrated Forceps Model of Spinal Cord Compression Injury
Jove Year: 2015
Jove Species: Mouse</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/ForelimbAsymmetryTest -->

    <owl:Class rdf:about="http://psink.de/scio/ForelimbAsymmetryTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <example>Sensorimotor Experience Influences Recovery of Forelimb Abilities but Not Tissue Loss after Focal Cortical Compression in Adult Rats</example>
        <examplesource>DOI: 10.1371/journal.pone.0016726</examplesource>
    </owl:Class>
    


    <!-- http://psink.de/scio/ForelimbHindlimbCoupling -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ForelimbHindlimbCoupling">
        <rdf:type rdf:resource="http://psink.de/scio/LocomotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ForelimbStrengthTest -->

    <owl:Class rdf:about="http://psink.de/scio/ForelimbStrengthTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <example>Whereas performance in the upward-facing orientation reflected forelimb strength (which should not have been affected by a lower thoracic SCI in otherwise healthy animals), performance facing downward measured coordinated hind limb motor function (22, 23, 30).</example>
        <exampleSource>doi:  10.1073/pnas.0306239101</exampleSource>
        <rdfs:comment>Also known as: Grip Strenght Meter Test</rdfs:comment>
        <rdfs:description>The physical strength of the forelimb is measured.</rdfs:description>
        <rdfs:videoReference>Jove Title: Measuring the Strength of Mice 
Jove Year: 2013
Jove Species: Mouse
Jove DOI: 10.3791/2610</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/Function -->

    <owl:Class rdf:about="http://psink.de/scio/Function"/>
    


    <!-- http://psink.de/scio/FunctionalTest -->

    <owl:Class rdf:about="http://psink.de/scio/FunctionalTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InvestigationMethod"/>
        <rdfs:description>Superclass for functional tests, e.g. locomotor tests, reflex tests etc. in the living animal.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GaitTest -->

    <owl:Class rdf:about="http://psink.de/scio/GaitTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/GaleRatingScoreTest -->

    <owl:Class rdf:about="http://psink.de/scio/GaleRatingScoreTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeurologicScalesTest"/>
        <example>For behavioral testing, we used a ‘motor function scale’ that is a slight modification of the ‘motor score’ of Gale et al.</example>
        <rdfs:description>Subclass of locomotor rating scales in functional tests for investigation.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GastricUlcerogenesisTest -->

    <owl:Class rdf:about="http://psink.de/scio/GastricUlcerogenesisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68014456</descriptionSource>
        <example>We used cervical spinal cord transection (CCT) in the rat to model these ulcers and examined the effect of core body temperature and vascular volume on gastric ulcerogenesis.</example>
        <exampleSource>PMID: 16240212</exampleSource>
        <rdfs:description>Formation of ulcers in the stomach.

Ulcer
A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Gelfoam -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Gelfoam">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=gelfoam</descriptionSource>
        <example>The operated control groups received grafts of either gelfoam or gelfoam with fibroblasts expressing GFP into the lesion site.</example>
        <exampleSource>PMID: 14637085</exampleSource>
        <rdfs:description>Sterile, gelatin-base surgical sponge applied topically as an adjunct to hemostasis when the control of bleeding by conventional procedures is ineffective to reduce capillary ooze or is impractical. (From AMA Drug Evaluations Annual, 1994, p797)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Gender -->

    <owl:Class rdf:about="http://psink.de/scio/Gender">
        <rdfs:description>According to information given in paper either male, female, or both, male and female.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GeneExpressionAnalysis -->

    <owl:Class rdf:about="http://psink.de/scio/GeneExpressionAnalysis">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MolecularChangesTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/GeneticModificationTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/GeneticModificationTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ModificationTreatment"/>
        <example>We here have demonstrated CRMP4 involvement in CSPG-induced inhibitory signaling and nociceptive recovery in Crmp4-/- mice after SCI.</example>
        <exampleSource>doi: 10.1016/j.mcn.2016.03.006</exampleSource>
        <rdfs:description>Genetic modification of the whole organisam.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GlialCell -->

    <owl:Class rdf:about="http://psink.de/scio/GlialCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Cell"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/GroomingObservation -->

    <owl:Class rdf:about="http://psink.de/scio/GroomingObservation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ObservationOfBehaviour"/>
        <example>Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats.</example>
        <examplesource>10.1089/neu.2006.23.36</examplesource>
        <rdfs:comment>Grooming behavior is observed.</rdfs:comment>
    </owl:Class>
    


    <!-- http://psink.de/scio/GuineaPigModel -->

    <owl:Class rdf:about="http://psink.de/scio/GuineaPigModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/GuineaPigSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68006168</descriptionSource>
        <rdfs:description>A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GuineaPigSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/GuineaPigSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/HarringtonDistractor -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/HarringtonDistractor">
        <rdf:type rdf:resource="http://psink.de/scio/DistractorDevices"/>
        <rdfs:appliedForInjuryType>Distraction</rdfs:appliedForInjuryType>
        <rdfs:introduced>Title: A model of experimental spinal cord trauma based on computer-controlled intervertebral distraction: characterization of graded injury.
Year: 2004
Species: Rat
PMID 15507795</rdfs:introduced>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/HemorrhageTest -->

    <owl:Class rdf:about="http://psink.de/scio/HemorrhageTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68006470</descriptionSource>
        <example>Our data show that E2 attenuated BSCB permeability and hemorrhage and reduced the infiltration of neutrophils and macorphages after SCI.</example>
        <exampleSource>doi: 10.1210/en.2014-1832</exampleSource>
        <rdfs:description>Bleeding or escape of blood from a vessel.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/HindpawSensationTest -->

    <owl:Class rdf:about="http://psink.de/scio/HindpawSensationTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SensoryTest"/>
        <example>Sensory threshold (ST) was measured using an electric von Frey anesthesiometer (VFA) in all limbs of 20 normal dogs and 29 dogs with acute thoracolumbar spinal cord injury (SCI) caused by spontaneous intervertebral disc extrusion.</example>
        <exampleSource>doi: 10.1016/j.tvjl.2015.07.028</exampleSource>
        <rdfs:description>Examination of sensation threshold in the hindpaws other than pain reception.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/HistologicalInvestgationTest -->

    <owl:Class rdf:about="http://psink.de/scio/HistologicalInvestgationTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonFunctionalTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68006653</descriptionSource>
        <rdfs:description>The study of the structure of various TISSUES of organisms on a microscopic level.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Hyperalgesia -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Hyperalgesia">
        <rdf:type rdf:resource="http://psink.de/scio/SensoryFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/HypothermiaBlanket -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/HypothermiaBlanket">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <example>In the mild hypothermia + NgR-silenced cells + PLGA group, the rats were placed on a cold blanket to maintain their rectal temperatures at 34 ± 0.5°C for 6 hours after cell transplantation.</example>
        <exampleSource>doi:  10.4103/1673-5374.147952</exampleSource>
        <rdfs:description>Instrument for cooling in the form of a blanket.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/HypothermicTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/HypothermicTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/TemperatureTreatment"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007035</descriptionSource>
        <rdfs:description>Lower than normal body temperature, especially in warm-blooded animals</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Hypothesis -->

    <owl:Class rdf:about="http://psink.de/scio/Hypothesis">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/StudyDesign"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ICOSCorporation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ICOSCorporation">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Ice -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Ice">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <example>TH treatment with moderate systemic hypothermia was achieved using the external application of an ice cube.</example>
        <exampleSource>DOI: 10.1097/BRS.0000000000000845</exampleSource>
        <rdfs:description>Ice cubes for cooling.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ImplantedDepotPellet -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ImplantedDepotPellet">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004343</descriptionSource>
        <example>In animals implanted with TAC pellets (3.4 mg/kg/day), a stable 3-month lasting plasma concentration of TAC averaging 19.1 ± 4.9 ng/ml was measured.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2013.05.017</exampleSource>
        <rdfs:description>Drug Implants
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/InVitroExperimentalProcedure -->

    <owl:Class rdf:about="http://psink.de/scio/InVitroExperimentalProcedure">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ExperimentalProcedure"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/InclinedPlaneTest -->

    <owl:Class rdf:about="http://psink.de/scio/InclinedPlaneTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <example>Behavioural testing of hindlimb function was initiated 3 days after injury using the Basso Beattie Bresnahan locomotor rating scale, and at 1 week using the inclined plane test.</example>
        <exampleSource>PMID: 12805103</exampleSource>
        <rdfs:description>Functional test for locomotion where the animals bevahiour on an inclined plane is tested.
Tests for:
strength in upper and lower limbs, 
ability to prevent from  falling over</rdfs:description>
        <rdfs:introduced>Title: Objective clinical assessment of motor function after experimental spinal cord injury in the rat.
Year: 1977
Species: rat
DOI: 10.3171/jns.1977.47.4.0577</rdfs:introduced>
    </owl:Class>
    


    <!-- http://psink.de/scio/InfectionExamination -->

    <owl:Class rdf:about="http://psink.de/scio/InfectionExamination">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicalExamination"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/InfiniteHorizonImpactor -->

    <owl:Class rdf:about="http://psink.de/scio/InfiniteHorizonImpactor">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/WeightDrop"/>
        <example>Contusion damage to the spinal cord at the 11th vertebra was performed by IH (Infinite Horizon) impactor, which applied a pressure of 50 kdyn.</example>
        <exampleSource>doi: 10.3390/ijms160715785</exampleSource>
        <rdfs:appliedForInjuryType>Contusion</rdfs:appliedForInjuryType>
        <rdfs:comment>Former OSU impactor</rdfs:comment>
        <rdfs:company>PSI (Precision Systems and Instrumentation, LCC)</rdfs:company>
        <rdfs:description>Instrument for accurate and specific weight drop on the exposed spinal cord.
force: 100-200 kdyn (100-150 kdyn corresponds to mild-moderate injury, 150-200 kdyn to moderate-severe injury)</rdfs:description>
        <rdfs:videoReference>1.
Jove DOI:10.3791/3313
Jove Title: A Contusive Model of Unilateral Cervical Spinal Cord Injury Using the Infinite Horizon Impactor
Jove Year: 2011
Jove Species: Rat.

2.
Jove DOi:  10.3791/50111
Jove Title: A Contusion Model of Severe Spinal Cord Injury in Rats
Jove Year: 2013
Jove Species: Rat</rdfs:videoReference>
        <rdfs:videoReference>http://www.presysin.com/Products/Infinite-Horizon-Impactor.aspx</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/InflammationTest -->

    <owl:Class rdf:about="http://psink.de/scio/InflammationTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonNeuronalCellChangesTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007249</descriptionSource>
        <example>Activated inflammation (evidenced by increased levels of IL-1β, TNF-α, and MPO but decreased levels of IL-10) caused by SCI was noted</example>
        <exampleSource>doi:10.1016/j.tjog.2015.12.009</exampleSource>
        <rdfs:description>Non-functional test for non-neuronal cell changes of inflammatory cells.

A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/InhalationDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/InhalationDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <example>Under inhalational anesthesia using halothane (1–2%) and a 1:1 mixture of O2/N2O, the surgical area was shaved and disinfected with 70% ethanol and betadine.</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.4184-05.2006</exampleSource>
        <rdfs:description>The exposure of a chemical, physical or biological agent by inhaling it.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Injury -->

    <owl:Class rdf:about="http://psink.de/scio/Injury">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Event"/>
        <rdfs:comment>Aggregation class for injury properties, like injury intensity, injury device etc.</rdfs:comment>
        <rdfs:description>Includes all the specific information regarding the injuryl model. Type of lesion, i.e. contusion, compression. As listed in drop down menu. Class of Aggregation within the injury paradigm.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/InjuryArea -->

    <owl:Class rdf:about="http://psink.de/scio/InjuryArea">
        <rdfs:description>Location inside the spinal cord, i.e. lateral, dorsal, or defined tract systems as dorsal columns.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/InjuryByAccident -->

    <owl:Class rdf:about="http://psink.de/scio/InjuryByAccident">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Event"/>
        <rdfs:description>This class models spinal cord injuries which are not caused by an experimentator on purpose but occur by circumstances which are uncontrolled like e.g. in an accident.
These injuries are characterized by their seveerity and also by their type.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/InjuryDevice -->

    <owl:Class rdf:about="http://psink.de/scio/InjuryDevice">
        <rdfs:description>Apparatus or instrument used for injury.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/InjuryIntensity -->

    <owl:Class rdf:about="http://psink.de/scio/InjuryIntensity">
        <rdfs:description>For example, mild, moderate, or severe.
Either stated in text or according to publications stating the identical injury paradigm or according to the BBB 1-7 days post lesion (BBB 0-7 severe, BBB 7-13 moderate, BBB 14-21 mild injury).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/IntramuscularDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/IntramuscularDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007273</descriptionSource>
        <example>Using a microsyringe (Hamilton, Reno, NV), each 100 µL of adenoviral vector encoding LacZ (5.0 × 108 PFU, n = 37) or BDNF (5.0 × 108 PFU, n = 23) was injected carefully and slowly into the middle belly of the superficial layer of the bilateral sternomastoid muscles simultaneously.</example>
        <exampleSource>DOI: 10.1097/BRS.0b013e3181b8e89b</exampleSource>
        <rdfs:description>Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/IntraperitonealDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/IntraperitonealDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007274</descriptionSource>
        <example>Briefly, animals were anaesthetized with 0.5 mg/kg intraperitoneal (i.p.) medetomidine (Domitor, LÄÄkefarmos, Finland) and 60 mg/kg i.p. ketamine (Ketalar, Parke-Davis, Sweden) and one jugular vein was cannulated.</example>
        <exampleSource>doi:10.1016/j.ejphar.2014.05.060</exampleSource>
        <rdfs:description>Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Intraspinal -->

    <owl:Class rdf:about="http://psink.de/scio/Intraspinal">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SpinalCord"/>
        <rdfs:description>Treatment application in the spinal cord tissue.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Intrathecal -->

    <owl:Class rdf:about="http://psink.de/scio/Intrathecal">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SpinalCord"/>
        <example>The spinal mESC-NPCs were intrathecally transplanted into the lesion area of the spinal cord around T10-T11 at 21 days after SCI.</example>
        <exampleSource>doi: 10.3727/096368915X689460</exampleSource>
        <rdfs:description>Injection of a substance or other treatment application into the spinal canal.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/IntravenousDelivery -->

    <owl:Class rdf:about="http://psink.de/scio/IntravenousDelivery">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68061605</descriptionSource>
        <rdfs:description>Delivery of substances through VENIPUNCTURE into the VEINS.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/InvestigationMethod -->

    <owl:Class rdf:about="http://psink.de/scio/InvestigationMethod">
        <rdfs:description>Laboratory procedures which is used to investigate the effect of a treatment.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/IridectomyScissors -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/IridectomyScissors">
        <rdf:type rdf:resource="http://psink.de/scio/Scissors"/>
        <example>After opening the dura mater, the dorsal spinal cord was symmetrically lesioned with fine iridectomy scissors (FST), resulting in a ≥ four-fifth hemisection.</example>
        <exampleSource>DOI: http://dx.doi.org/10.1093/brain/awv375 awv375</exampleSource>
        <rdfs:description>Surcial instrument normally used for eye surgery, in this context used to perform a cut of the spinal cord.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/IrisClip -->

    <owl:Class rdf:about="http://psink.de/scio/IrisClip">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Clip"/>
        <example>Compressive injury was produced by transient extradural application of a modified iris clip, which exerts a force of about 95 g on the spinal cord for 1 min.</example>
        <exampleSource>doi:10.1038/sj.sc.3101878</exampleSource>
        <rdfs:description>Small surgical instrument used in eye surgery.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Judgement -->

    <owl:Class rdf:about="http://psink.de/scio/Judgement">
        <rdfs:description>Judgement for the value of a result for the treatment of spinal cord injury as stated by author, can be ʺpositiveʺ or ʺnegativeʺ or ʺno effectʺ.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/KeepingCondition -->

    <owl:Class rdf:about="http://psink.de/scio/KeepingCondition">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalCareCondition"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/LadderRungTest -->

    <owl:Class rdf:about="http://psink.de/scio/LadderRungTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/LocomotorTest"/>
        <example>Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination.</example>
        <examplesource>PMID 11992668</examplesource>
        <rdfs:comment>or &quot;GridWalk&quot;</rdfs:comment>
        <rdfs:description>The animals walk over a horizontal ladder and missteps are counted and/or rated.
Tests for 
fore- and hindlimb stepping, 
fine motor control, 
foot placing accuracy, 
sensory motor coordination .</rdfs:description>
        <rdfs:videoReference>Jove Title: The Ladder Rung Walking Task: A Scoring System and its Practical Application.
Jove Year: 2009
Jove Species: Rat
Jove DOI: 10.3791/1204</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/Laminectomy -->

    <owl:Class rdf:about="http://psink.de/scio/Laminectomy">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=laminectomy</descriptionSource>
        <example>38 adult male Sprague-Dawley rats were randomly divided into 5 groups: only laminectomy, laminectomy and trauma, laminectomy trauma and Alpha Lipoic Acid 100 mg/kg IP administration, laminectomy trauma and N-Acetyl Cysteine 300 mg/kg IP administration, and vehicle group (PEG).</example>
        <exampleSource>doi: 10.5137/1019-5149.JTN.14594-15.0</exampleSource>
        <rdfs:description>A surgical procedure that entails removing all (laminectomy) or part (laminotomy) of selected vertebral lamina to relieve pressure on the SPINAL CORD and/or SPINAL NERVE ROOTS. Vertebral lamina is the thin flattened posterior wall of vertebral arch that forms the vertebral foramen through which pass the spinal cord and nerve roots.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/LateralHemisection -->

    <owl:Class rdf:about="http://psink.de/scio/LateralHemisection">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PartialTransection"/>
        <example>Injured animals received a high cervical (C2) lateral hemisection (Hx), which compromises supraspinal input to ipsilateral spinal motoneurons controlling the upper extremities (forelimb) in the adult rat.</example>
        <exampleSource>doi: 10.1089/neu.2014.3718</exampleSource>
        <rdfs:description>Partial transection of the lateral aspect of the spinal cord at one side.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Left -->

    <owl:Class rdf:about="http://psink.de/scio/Left">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Direction"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Lentivirus -->

    <owl:Class rdf:about="http://psink.de/scio/Lentivirus">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Retrovirus"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68016086</descriptionSource>
        <rdfs:description>A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3&apos; env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/LesionAdjacentTissue -->

    <owl:Class rdf:about="http://psink.de/scio/LesionAdjacentTissue">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SpinalCord"/>
        <example>Massive increases of S100beta and FGF-2 were found in reactive astrocytes, not in reactive microglia, in the border and in the white and gray matters of adjacent preserved tissue of the contused spinal cord in the periods studied.</example>
        <exampleSource>PMID: 17244329</exampleSource>
        <rdfs:description>Tissue excluding the spinal cord lesion core, but adjacent to it.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/LesionVolumeTest -->

    <owl:Class rdf:about="http://psink.de/scio/LesionVolumeTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
 <rdfs:description>Analysis of the lesion volume in the tissue post-mortem.</rdfs:description>
        <example>Stereological tissue-volume analysis determined that females, more so than males, also exhibited greater volumes of preserved gray and white matter within the injured cord segment as well as more spared ventral white matter area at the center of the lesion.</example>
    </owl:Class>
    


    <!-- http://psink.de/scio/LethargyObservation -->

    <owl:Class rdf:about="http://psink.de/scio/LethargyObservation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ObservationOfBehaviour"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=lethargy</descriptionSource>
        <example>All rats appeared lethargic for the entire duration of riluzole treatment.</example>
        <exampleSource>doi:  10.1089/neu.2012.2622</exampleSource>
        <rdfs:description>A general state of sluggishness, listless, or uninterested, with being tired, and having difficulty concentrating and doing simple tasks. It may be related to DEPRESSION or DRUG ADDICTION.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/LightSource -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/LightSource">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <example>Morphofunctional changes in the rat spinal cord after focal photothrombosis</example>
        <examplesource>DOI: 10.1038/srep09640</examplesource>
        <rdfs:appliedForInjuryType>Chemical Injury, Photothrombosis</rdfs:appliedForInjuryType>
        <rdfs:description>A photoactive dye is infused into the spinal cord and injury is applied by irradiation under a microscope</rdfs:description>
        <rdfs:videoReference>Jove Title: Photothrombosis-induced Focal Ischemia as a Model of Spinal Cord Injury in Mice
Jove Year: 2015
Jove Species: Mouse
Jove DOI:10.3791/53161</rdfs:videoReference>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/LimbMuscleStrengthTest -->

    <owl:Class rdf:about="http://psink.de/scio/LimbMuscleStrengthTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/LocomotorFunction -->

    <owl:Class rdf:about="http://psink.de/scio/LocomotorFunction">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Function"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/LocomotorTest -->

    <owl:Class rdf:about="http://psink.de/scio/LocomotorTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <example>Behavioral tests. Basso, Beattie, and Bresnahan (BBB) locomotor scale, grid walking, and footprint analysis were used to evaluate functional recovery.</example>
        <exampleSource>DOI: http://dx.doi.org/10.3727/096368912X661373</exampleSource>
        <rdfs:description>A laboratory test for the assessment of locomotor function.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Longitude -->

    <owl:Class rdf:about="http://psink.de/scio/Longitude">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/LouisvilleSwimScale -->

    <owl:Class rdf:about="http://psink.de/scio/LouisvilleSwimScale">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SwimmingTest"/>
        <rdfs:introduced>Title: The Louisville Swim Scale: A Novel Assessment of Hindlimb Function following Spinal Cord Injury in Adult Rats
Year: 2008
Species: Rat
DOI:10.1089/neu.2006.23.1654</rdfs:introduced>
    </owl:Class>
    


    <!-- http://psink.de/scio/MASCISImpactor -->

    <owl:Class rdf:about="http://psink.de/scio/MASCISImpactor">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/WeightDrop"/>
        <example>Adult female Sprague Dawley rats (~230 g) received a moderate contusion to the thoracic (T9-T10) spinal cord, using the MASCIS impactor device.</example>
        <exampleSource>PMID: 26896212</exampleSource>
        <rdfs:description>Instrument for accurate and specific weight drop on the exposed spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MagneticFieldApplication -->

    <owl:Class rdf:about="http://psink.de/scio/MagneticFieldApplication">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ElectromagneticField"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ManualDexterityTest -->

    <owl:Class rdf:about="http://psink.de/scio/ManualDexterityTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <example>In 12 iSCI patients and matched controls, MEPs (evoked at 20% of maximal voluntary contraction [MVC]) were combined with a comprehensive ankle motor assessment protocol that measured ankle dorsiflexor strength (MVC, manual muscle testing, maximal movement velocity [MMV]), dexterity (the ability to accurately time ankle dorsiflexion movements) and gait (speed, walking aids).</example>
        <exampleSource>PMID: 18419251</exampleSource>
        <rdfs:description>Functional test of hand locomotion.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Matrix -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Matrix">
        <rdf:type rdf:resource="http://psink.de/scio/Compound"/>
        <example>Five weeks after dorsal thoracic hemisection injury the lesion scar was resected via aspiration and the resulting cavity was filled with different biopolymers such as Matrigel™, alginate-hydrogel and polyethylene glycol 600 (PEG) all of which have not previously been used as sole graft-materials in chronic SCI.</example>
        <exampleSource>doi: 10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:description>Injection of a matrix into the spinal cord.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MeanValue -->

    <owl:Class rdf:about="http://psink.de/scio/MeanValue">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NumericValue"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MechanicalAllodyniaTest -->

    <owl:Class rdf:about="http://psink.de/scio/MechanicalAllodyniaTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PainTest"/>
        <example>AIDA reduces glutamate release and attenuates mechanical allodynia after SCI.</example>
        <exampleSource>PMID: 11043525</exampleSource>
        <rdfs:description>Testing of an increased sensation of pain or discomfort produced by a non-noxious stimulus.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MedianValue -->

    <owl:Class rdf:about="http://psink.de/scio/MedianValue">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NumericValue"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MedicalExamination -->

    <owl:Class rdf:about="http://psink.de/scio/MedicalExamination">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InvestigationMethod"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MedicationDuringSurgery -->

    <owl:Class rdf:about="http://psink.de/scio/MedicationDuringSurgery">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalCareCondition"/>
        <rdfs:description>Additional medication to the anaethetic during surgery which is independent from the treatment for spinal cord injury.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MinipigModel -->

    <owl:Class rdf:about="http://psink.de/scio/MinipigModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/MinipigSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://en.wikipedia.org/wiki/Miniature_pig</descriptionSource>
        <example>Using our previously characterized porcine model of SCI, we subjected animals to resonance vibration (5.7±0.46 Hz) or no vibration for a period of 1.5 or 3.0 h.</example>
        <exampleSource>doi: 10.1089/neu.2014.3707</exampleSource>
        <rdfs:description>A miniature pig (also mini pig, or micro pig, or teacup pig) is a breed of pig developed and used for medical research or for use as a pet. Miniature pigs weigh between 75 pounds (34 kg) to 150 pounds (68 kg) when fully grown, while farm pigs may weigh more than 700 pounds (320 kg). They were first used for medical research in Europe before being introduced to the United States in the 1980s.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MinipigSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/MinipigSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ModificationTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/ModificationTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:description>Mostly experimental setting of genetically modified animals which are spinal cord injured to investigate the role of certain molecules.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MolecularChangesTest -->

    <owl:Class rdf:about="http://psink.de/scio/MolecularChangesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonFunctionalTest"/>
        <example>The levels of the HIF-1α, Bcl-2, Bax and VEGF proteins were explored using western blotting.</example>
        <exampleSource>PMID: 26927342</exampleSource>
        <rdfs:comment>No annotations are to be carried out with this  class. It merely exists in this ontology for its complete representation of concepts.</rdfs:comment>
        <rdfs:description>Non-functional investigation method using molecular biology methods. No annotations are to be carried out with this  class. It merely exists in this ontology for its complete representation of concepts.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MonkeyModel -->

    <owl:Class rdf:about="http://psink.de/scio/MonkeyModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/MonkeySpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68000882</descriptionSource>
        <rdfs:description>Haplorhini
A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MonkeySpecies -->

    <owl:Class rdf:about="http://psink.de/scio/MonkeySpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MortalityObservation -->

    <owl:Class rdf:about="http://psink.de/scio/MortalityObservation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ObservationOfBehaviour"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MotorEvokedPotentialsTest -->

    <owl:Class rdf:about="http://psink.de/scio/MotorEvokedPotentialsTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ElectrophysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=motor+evoked+potential</descriptionSource>
        <example>MEPs were elicited by applying constant current anodal stimuli to the sensorimotor cortex with the responses recorded from microelectrodes in the spinal cord at T-10.</example>
        <exampleSource>PMID: 3808252</exampleSource>
        <rdfs:description>The electrical response evoked in a muscle or motor nerve by electrical or magnetic stimulation. Common methods of stimulation are by transcranial electrical and TRANSCRANIAL MAGNETIC STIMULATION. It is often used for monitoring during neurosurgery.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MotorFunction -->

    <owl:Class rdf:about="http://psink.de/scio/MotorFunction">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Function"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MotorReflexTest -->

    <owl:Class rdf:about="http://psink.de/scio/MotorReflexTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=reflex+motor</descriptionSource>
        <example>To investigate the reflex response to heat-induced stimulus, tail-flick test was monitored in treated animals up to 16 days after SCI.
The single dose of NNLA (60 mg/kg) applied on the 10th day after SCI or Baclofen therapy reduced nNOS expression in α-motoneurons and suppressed symptoms of increased reflex activity.</example>
        <exampleSource>doi: 10.1016/j.spinee.2014.08.013</exampleSource>
        <rdfs:description>Reflex, Abdominal

Contractions of the abdominal muscles upon stimulation of the skin (superficial abdominal reflex) or tapping neighboring bony structures (deep abdominal reflex). The superficial reflex may be weak or absent, for example, after a stroke, a sign of upper (suprasegmental) motor neuron lesions. (Stedman, 25th ed and Best and Taylor&apos;s Physiological Basis of Medical Practice, 12th ed, p1073)</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MotorTest -->

    <owl:Class rdf:about="http://psink.de/scio/MotorTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MouseModel -->

    <owl:Class rdf:about="http://psink.de/scio/MouseModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/MouseSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68051379</descriptionSource>
        <rdfs:description>Animal of  the genus Mus.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/MouseSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/MouseSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/MyelinationTest -->

    <owl:Class rdf:about="http://psink.de/scio/MyelinationTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeuronalChangesTest"/>
        <example>As revealed by electron microscopy, bundles of regenerating axons within the matrix area received myelin ensheathment from Schwann cells.</example>
        <exampleSource>doi: 10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:description>Investigation of myelination as neuronal cell change. Myelination of axons is usually investigated in the lesioned area where regrowing axons occur.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NS398 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/NS398">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=ns-398</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/NYUImpactor -->

    <owl:Class rdf:about="http://psink.de/scio/NYUImpactor">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/WeightDrop"/>
        <example>Adult Wistar rats (n = 6) underwent traumatic thoracic cord contusion by an NYU impactor.</example>
        <exampleSource>PMID: 26931783</exampleSource>
        <rdfs:appliedForInjuryType>Contusion</rdfs:appliedForInjuryType>
        <rdfs:description>Instrument for accurate and specific weight drop on the exposed spinal cord.</rdfs:description>
        <rdfs:introduced>Title: Experimental modeling of spinal cord injury: characterization of a force-defined injury device. 
Year: 2003
Species: rat.
DOI: 10.1089/08977150360547099</rdfs:introduced>
    </owl:Class>
    


    <!-- http://psink.de/scio/NarrowBeamTest -->

    <owl:Class rdf:about="http://psink.de/scio/NarrowBeamTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/GaitTest"/>
        <example>Methods to Assess the Development and Recovery of Locomotor Function after Spinal Cord Injury in Rats</example>
        <examplesource>10.1006/exnr.1993.1017</examplesource>
        <rdfs:description>The animal crosses a narrow beam. Tests for paw placement and balance.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NeurogenesisTest -->

    <owl:Class rdf:about="http://psink.de/scio/NeurogenesisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeuronalChangesTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68055495</descriptionSource>
        <example>With NT3-chitosan, endogenous NSCs and their progenies were effectively activated and attracted to migrate into the NT3-chitosan tubes and subsequently differentiate into neurons, which matured to form a nascent functional synaptic network.</example>
        <exampleSource>doi: 10.1073/pnas.1510194112</exampleSource>
        <rdfs:description>Formation of NEURONS which involves the differentiation and division of STEM CELLS in which one or both of the daughter cells become neurons.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NeurologicScalesTest -->

    <owl:Class rdf:about="http://psink.de/scio/NeurologicScalesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/2009698</descriptionSource>
        <rdfs:description>Behavior Rating Scale
Instrument designed to assess human or animal behavior, using a standardized format.</rdfs:description>
        <rdfs:description>Scoring systems for motor and/or sensory function as investigation method.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NeuronalActivityTest -->

    <owl:Class rdf:about="http://psink.de/scio/NeuronalActivityTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeuronalChangesTest"/>
        <example>Though improved regeneration did not enhance locomotor function, we wanted to further assess integration of the regenerated axons by examining the extent of c-Fos induction in spinal cord caudal to the PNG upon stimulation of spinal cord rostral to the PNG. We found that there was no significant difference in the numbers of c-Fos+ neurons (Fig. 1g).</example>
        <exampleSource>doi:  10.1016/j.expneurol.2014.10.013</exampleSource>
        <rdfs:description>Investigation of neuronal activity as neuronal cell change. Marker for the electrophysiological activity of neurons are used in this histological method.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NeuronalCellLossTest -->

    <owl:Class rdf:about="http://psink.de/scio/NeuronalCellLossTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeuronalChangesTest"/>
  <rdfs:description>Test for the failure of neuroprotection, here loss of neuronal cells.</rdfs:description>
        <exampleSource>doi:  10.1186/1471-2202-14-146</exampleSource>
        <example>Intraperitoneal treatment with MnTBAP + nitro-L-arginine significantly reduced motoneuron and cell loss and apoptosis in the gray and white matter compared with the vehicle-treated group.</example>
    </owl:Class>
    


    <!-- http://psink.de/scio/NeuronalChangesTest -->

    <owl:Class rdf:about="http://psink.de/scio/NeuronalChangesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/HistologicalInvestgationTest"/>
        <rdfs:description>Investigation of neuronal cell change.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NeuroprotectionTest -->

    <owl:Class rdf:about="http://psink.de/scio/NeuroprotectionTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeuronalChangesTest"/>
  <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=neuroprotection</descriptionSource>
        <example>Cavity areas significantly decreased and the number of ventral motor neurons significantly increased in the Lav 200 and Lav 400 groups.</example>
        <rdfs:description>The physiological processes and techniques used by the body to prevent neuronal injury and degeneration in the central nervous system following acute disorders or as a result of chronic neurodegenerative diseases.</rdfs:description>
        <exampleSource>doi: 10.3389/fnins.2016.00025</exampleSource>
    </owl:Class>
    


    <!-- http://psink.de/scio/No5DumontForeceps -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/No5DumontForeceps">
        <rdf:type rdf:resource="http://psink.de/scio/Forceps"/>
        <example>This surgical SCI model is generated using a pair of No. 5 Dumont forceps modified to be held apart at a defined distance by either metal epoxy or some other obstruction to prevent complete closure.</example>
        <exampleSource>doi: 10.3791/52318</exampleSource>
        <rdfs:description>Specific type of forceps often used in experimental spinal cord injury studies for compression of the spinal cord.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/NonFunctionalTest -->

    <owl:Class rdf:about="http://psink.de/scio/NonFunctionalTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InvestigationMethod"/>
        <rdfs:description>Investigation methods which are no functional tests in the living animal, e.g. histology.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NonNeuronalCellChangesTest -->

    <owl:Class rdf:about="http://psink.de/scio/NonNeuronalCellChangesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/HistologicalInvestgationTest"/>
        <rdfs:description>Changes in any other cell types than neurons.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NormothermicTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/NormothermicTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/TemperatureTreatment"/>
        <rdfs:description>Normal body temperature of the subject.</rdfs:description>
    </owl:Class>
    



    <!-- http://psink.de/scio/NucleicAcid -->

    <owl:Class rdf:about="http://psink.de/scio/NucleicAcid">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Compound"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68009696</descriptionSource>
        <rdfs:description>High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NumericValue -->

    <owl:Class rdf:about="http://psink.de/scio/NumericValue">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/OSUImpactor -->

    <owl:Class rdf:about="http://psink.de/scio/OSUImpactor">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/WeightDrop"/>
        <example>With half of the animal&apos;s weight suspended, the animal was positioned under the Ohio State University (OSU) Impactor, and the impactor tip was gently lowered to apply a pre-load force of 0.2 kdyn onto the dura.</example>
        <exampleSource>doi:10.1016/j.expneurol.2009.11.006</exampleSource>
        <rdfs:description>The OSU or Ohio State University Impactor is an instrument for accurate and specific weight drop on the exposed spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Observation -->

    <owl:Class rdf:about="http://psink.de/scio/Observation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Event"/>
        <rdfs:description>Observation as the result of an experiment.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ObservationOfBehaviour -->

    <owl:Class rdf:about="http://psink.de/scio/ObservationOfBehaviour">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InvestigationMethod"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/OligodendrogliaChangesTest -->

    <owl:Class rdf:about="http://psink.de/scio/OligodendrogliaChangesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonNeuronalCellChangesTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=oligodendroglia</descriptionSource>
        <example>Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat.</example>
        <rdfs:description>A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/OpenFieldTest -->

    <owl:Class rdf:about="http://psink.de/scio/OpenFieldTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NeurologicScalesTest"/>
        <example>All animals were gentled prior to injury so that they were comfortable being handled and walking in the open field apparatus.</example>
        <exampleSource>doi:  10.1186/1742-2094-10-20</exampleSource>
        <rdfs:description>Functional test for locomotion in an open field where the animal can move freely. There are multiple aspects that can be monitored in this arrangement. Usually, neurologic scales are used to grade the animals locomotor skills.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/OpenLabelStudy -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/OpenLabelStudy">
        <rdf:type rdf:resource="http://psink.de/scio/ExperimentalMethod"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/OralDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/OralDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=oral+administration</descriptionSource>
        <example>PEAP behavior was also reduced in animals administered daily with oral UR13870 (10mg/kg p.o.) and preserved spinal tissue 28 days after SCI.</example>
        <exampleSource>doi: 10.1016/j.pain.2014.08.030</exampleSource>
        <rdfs:description>The giving of drugs, chemicals, or other substances by mouth.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/OrganismModel -->

    <owl:Class rdf:about="http://psink.de/scio/OrganismModel"/>
    


    <!-- http://psink.de/scio/OscillatingFieldStimulator -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/OscillatingFieldStimulator">
        <rdf:type rdf:resource="http://psink.de/scio/Electrodes"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/OsmoticMinipump -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/OsmoticMinipump">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <example>Immediately afterwards, the energy substrate acetyl-l-carnitine (ALC; 1 mg/day) or phosphate-buffered saline (PBS) was infused intrathecally (sub-arachnoid) for 6 days via an L5/6 catheter attached to a subcutaneous Alzet pump.</example>
        <exampleSource>doi: 10.1089/neu.2015.4030</exampleSource>
        <rdfs:description>Implantable pump for slow substance release by osmotic pressure.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/OvariectomyTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/OvariectomyTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SurgicalTreatment"/>
        <example>The aim of the present study was to determine whether administration of GnRH improves locomotor activity, urinary function and neurofilament (NFs) protein expression after spinal cord injury (SCI) in ovariectomized rats.</example>
        <exampleSource>doi: 10.1016/j.neulet.2012.03.052.</exampleSource>
        <rdfs:description>The surgical removal of one or both ovaries.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/OxidativeStressTest -->

    <owl:Class rdf:about="http://psink.de/scio/OxidativeStressTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68018384</descriptionSource>
        <example>UA is considered a potent peroxinitrite scavenger shown to be neuroprotective during oxidative stress conditions both in vitro and in vivo.</example>
        <rdfs:description>A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).

Measurement of the MPO activity is a standard test for oxidative stress.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/PainTest -->

    <owl:Class rdf:about="http://psink.de/scio/PainTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68010146</descriptionSource>
        <rdfs:description>Pain
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.</rdfs:description>
        <rdfs:description>Pain is a concept which is investigated with very specialized tests. In SCIO it is categorized as a sensory test under the functional test class in investigation methods, although pain pathways are different to sensory pathways.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/PartialTransection -->

    <owl:Class rdf:about="http://psink.de/scio/PartialTransection">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Injury"/>
        <rdfs:description>Partial cutting lesion of the spinal cord, resulting in incomplete spinal cord injury which leaves a certain amount of the grey and/or white matter intact.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Person -->

    <owl:Class rdf:about="http://psink.de/scio/Person">
        <rdfs:description>Author of the study.</rdfs:description>
    </owl:Class>
    


    


    <!-- http://psink.de/scio/PhysicalImplantTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/PhysicalImplantTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysicalTreatment"/>
        <example>Here, we describe a mechanical microconnector system (mMS) to re-adjust the retracted spinal cord stumps. The mMS is a multi-channel system of polymethylmethacrylate (PMMA), designed to fit into the spinal cord tissue gap after transection, with an outlet tubing system to apply negative pressure to the mMS thus sucking the spinal cord stumps into the honeycomb-structured holes.</example>
        <exampleSource>doi:10.1016/j.biomaterials.2013.09.057</exampleSource>
        <rdfs:description>Implanted device which influences physical attributed of the tissue after spinal cord injury, e.g. implantation of a vertebra stabilizing device.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/PhysicalTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/PhysicalTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Treatment"/>
        <rdfs:description>Any physical treatment which involves temperature, radiation, vibration, movement, electrostimulation etc.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/PhysiologyTest -->

    <owl:Class rdf:about="http://psink.de/scio/PhysiologyTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68010827</descriptionSource>
        <rdfs:description>Physiology
The biological science concerned with the life-supporting properties, functions, and processes of living organisms or their parts.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Poloxamer -->

    <owl:Class rdf:about="http://psink.de/scio/Poloxamer">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68020442</descriptionSource>
        <rdfs:description>A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO(C2H4O)a(-C3H6O)b(C2H4O)aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. (Martindale The Extra Pharmacopoeia, 31st ed)</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/PostSurgeryCondition -->

    <owl:Class rdf:about="http://psink.de/scio/PostSurgeryCondition">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalCareCondition"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/PostsurgicalMedication -->

    <owl:Class rdf:about="http://psink.de/scio/PostsurgicalMedication">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PostSurgeryCondition"/>
        <example>Cyclosporine (10 mg/kg, subcutaneously) was administered daily to all rats in every group beginning the day of transplantation.</example>
        <exampleSource>doi:10.1038/70986</exampleSource>
        <rdfs:description>Medication of pain, immunosuppression, antibiotic medication and other medications which are not directly related to the treatment applied.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Pressure -->

    <owl:Class rdf:about="http://psink.de/scio/Pressure">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Protein -->

    <owl:Class rdf:about="http://psink.de/scio/Protein">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Compound"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68011506</descriptionSource>
        <rdfs:description>Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ProteinLevelAnalysis -->

    <owl:Class rdf:about="http://psink.de/scio/ProteinLevelAnalysis">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MolecularChangesTest"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Publication -->

    <owl:Class rdf:about="http://psink.de/scio/Publication">
        <rdfs:description>Information about the publication.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Quadsection -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Quadsection">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>A cavity of approximately 3 mm wide and 5–6 mm deep was created by aspiration in the right dorsal quadrant of the T1 spinal cord.</example>
        <exampleSource>doi:  10.1016/j.expneurol.2010.06.011</exampleSource>
        <rdfs:description>Injury of one quarter of the spinal cord in cross section.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RNA -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RNA">
        <rdf:type rdf:resource="http://psink.de/scio/NucleicAcid"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68012313</descriptionSource>
        <rdfs:description>A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Randomization -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Randomization">
        <rdf:type rdf:resource="http://psink.de/scio/StudyDesign"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RatModel -->

    <owl:Class rdf:about="http://psink.de/scio/RatModel">
        <owl:equivalentClass>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasSpecies"/>
                <owl:allValuesFrom rdf:resource="http://psink.de/scio/RatSpecies"/>
            </owl:Restriction>
        </owl:equivalentClass>
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalModel"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68051381</descriptionSource>
        <rdfs:description>Animals of the genus Rattus.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/RatSpecies -->

    <owl:Class rdf:about="http://psink.de/scio/RatSpecies">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/AnimalSpecies"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/RearingTest -->

    <owl:Class rdf:about="http://psink.de/scio/RearingTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <example>Here we showed that, with the exception of a modest improvement in performance on the Montoya staircase test at 8-10 weeks postinjury, the combinatorial treatment with ghrelin, ibuprofen, C16, and KD did not result in any significant improvements in the rearing test, grooming test, or horizontal ladder.</example>
        <exampleSource>PMID: 24658967</exampleSource>
        <rdfs:description>Rearing is normally investigated in a glass cylinder. The forelimb contact to the glass wall is counted. Nevertheless, other setups for measurement of rearing are also possible.
Tests for: 
locomotor asymetry, 
hind limb strength, 
forelimb activity.</rdfs:description>
        <rdfs:videoReference>Jove title: Unilateral Pyramidotomy of the Corticospinal Tract in Rats for Assessment of Neuroplasticity-inducing Therapies
Jove Year: 2014
Jove Species: Rat
Jove DOI: 10.3791/51843</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/Recovery -->

    <owl:Class rdf:about="http://psink.de/scio/Recovery">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Observation"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/RegularWalkingPattern -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RegularWalkingPattern">
        <rdf:type rdf:resource="http://psink.de/scio/LocomotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RehabilitativeTraining -->

    <owl:Class rdf:about="http://psink.de/scio/RehabilitativeTraining">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysicalTreatment"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Result -->

    <owl:Class rdf:about="http://psink.de/scio/Result">
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasObservation"/>
                <owl:minQualifiedCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#nonNegativeInteger">1</owl:minQualifiedCardinality>
                <owl:onClass rdf:resource="http://psink.de/scio/Observation"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasInvestigationMethod"/>
                <owl:qualifiedCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#nonNegativeInteger">1</owl:qualifiedCardinality>
                <owl:onClass rdf:resource="http://psink.de/scio/InvestigationMethod"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasReferenceGroup"/>
                <owl:qualifiedCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#nonNegativeInteger">1</owl:qualifiedCardinality>
                <owl:onClass rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasStatisticalTest"/>
                <owl:qualifiedCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#nonNegativeInteger">1</owl:qualifiedCardinality>
                <owl:onClass rdf:resource="http://psink.de/scio/StatisticalTest"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:subClassOf>
            <owl:Restriction>
                <owl:onProperty rdf:resource="http://psink.de/scio/hasTargetGroup"/>
                <owl:qualifiedCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#nonNegativeInteger">1</owl:qualifiedCardinality>
                <owl:onClass rdf:resource="http://psink.de/scio/ExperimentalGroup"/>
            </owl:Restriction>
        </rdfs:subClassOf>
        <rdfs:description>Represents the findings of a study. There can be more than one result.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Retransection -->

    <owl:Class rdf:about="http://psink.de/scio/Retransection">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Event"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Retrovirus -->

    <owl:Class rdf:about="http://psink.de/scio/Retrovirus">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Virus"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68012190</descriptionSource>
        <rdfs:description>Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Right -->

    <owl:Class rdf:about="http://psink.de/scio/Right">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Direction"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Rostral -->

    <owl:Class rdf:about="http://psink.de/scio/Rostral">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Direction"/>
        <example>One week after injury, 2 times 106 SCs in 6 mul DMEM-F12 medium were injected into the contused area. Immediately after SC grafting, 0.25 mul of either endotoxin-free sterile saline or 50 mM db-cAMP was injected into the spinal cord on either side of the midline, both rostral and caudal to the SC graft at a depth of 0.5 mm.</example>
        <exampleSource>doi:10.1038/nm1056</exampleSource>
        <rdfs:description>Application of a treatment rostral to the lesion site.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Sacrifice -->

    <owl:Class rdf:about="http://psink.de/scio/Sacrifice">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Event"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/ScarringTest -->

    <owl:Class rdf:about="http://psink.de/scio/ScarringTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/HistologicalInvestgationTest"/>
        <example>Following transection of the dorsal corticospinal tract (CST) at thoracic level 8 in adult rats, transient suppression of collagenous scarring in the lesion zone by local application of a potent iron chelator and cyclic adenosine monophosphate resulted in the delay of fibrous scarring.</example>
        <exampleSource>PMID: 16367771</exampleSource>
        <rdfs:description>The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SchwannCellChangesTest -->

    <owl:Class rdf:about="http://psink.de/scio/SchwannCellChangesTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/NonNeuronalCellChangesTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68012583</descriptionSource>
        <example>As revealed by electron microscopy, bundles of regenerating axons within the matrix area received myelin ensheathment from Schwann cells.</example>
        <exampleSource>doi: 10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:description>Subclass of investigation method/non-functional tests/histology for the non-neuronal cell type Schwann cells.

Neuroglial cells of the peripheral nervous system which form the insulating myelin sheaths of peripheral axons.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Scissors -->

    <owl:Class rdf:about="http://psink.de/scio/Scissors">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:description>Surcial instrument used to perform a cut of the spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ScoutenWireKnife -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ScoutenWireKnife">
        <rdf:type rdf:resource="http://psink.de/scio/CuttingDevice"/>
        <example>In brief, under
isoﬂurane anaesthesia (..) the dura of adult female Wistar rats was opened
at thoracic level 8 (Th8) and the dorsal CST, dorsal coloumns and the
central canal were cut with a Scouten wire knife (Bilaney, Germany) to
give a U-shaped lesion (...).</example>
        <exampleSource>doi:10.1111/j.1460-9568.2005.04495.x</exampleSource>
        <rdfs:appliedForInjuryType>Partial transections</rdfs:appliedForInjuryType>
        <rdfs:comment>McHugh Milieux Wire Knife</rdfs:comment>
        <rdfs:company>McHugh Milieux</rdfs:company>
        <rdfs:description>Retractable wire knife system.</rdfs:description>
        <rdfs:weblink>http://www.mchughmilieux.com/</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SecondaryDegenerationTest -->

    <owl:Class rdf:about="http://psink.de/scio/SecondaryDegenerationTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/HistologicalInvestgationTest"/>
        <example>Notably, this treatment resulted in a significant reduction of secondary tissue loss and functional deficit.</example>
        <exampleSource>PMID: 14637115</exampleSource>
        <rdfs:description>Process of degeneration of tissue after the initial impact. This process can last for several days or weeks after spinal cord injury.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Sedative -->

    <owl:Class rdf:about="http://psink.de/scio/Sedative">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicationDuringSurgery"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/SensoryFunction -->

    <owl:Class rdf:about="http://psink.de/scio/SensoryFunction">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Function"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/SensoryTest -->

    <owl:Class rdf:about="http://psink.de/scio/SensoryTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/FunctionalTest"/>
        <example>Sensory thresholds can be measured reliably in chondrodystrophoid dogs and are altered by SCI. The differences in sensation among neurologic grades indicate that these techniques can be used to further characterize recovery of SCI dogs.</example>
        <exampleSource>doi: 10.1111/jvim.13913</exampleSource>
        <rdfs:description>Testing of sensory function as functional investigation method.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Significance -->

    <owl:Class rdf:about="http://psink.de/scio/Significance">
        <example>We also observed the trend of augmented CST axons at a lower level of transverse spinal cord sections 11–15 mm distal to SCI in the ibuprofen-treated rats, although the difference between ibuprofen and control groups did not reach statistical significance (P&lt;0.05).</example>
        <rdfs:description>The significance is indicated by the p-value. A mere statement of significance by the author is not considered significant. Significance has to be supported by data.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SingleBlindStudy -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SingleBlindStudy">
        <rdf:type rdf:resource="http://psink.de/scio/ExperimentalMethod"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SinglePelletReachingTest -->

    <owl:Class rdf:about="http://psink.de/scio/SinglePelletReachingTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <example>Skilled reaching an action pattern: stability in rat (Rattus norvegicus) grasping movements as a function of changing food pellet size.</example>
        <examplesource>PMID 11080542</examplesource>
        <rdfs:description>The rat or mouse reaches for pellets with its forepaws and video recordings are analyzed in slow motion.
Tests for:
skilled forepaw use, 
gripping ability.</rdfs:description>
        <rdfs:videoReference>Jove Title: Study Motor Skill Learning by Single-pellet Reaching Tasks in Mice
Jove Year: 2014
Jove Species: Mouse
Jove DOI:10.3791/51238</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/SomatosensoryEvokedPotentialsTest -->

    <owl:Class rdf:about="http://psink.de/scio/SomatosensoryEvokedPotentialsTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ElectrophysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=somatosensory+evoked+potential</descriptionSource>
        <example>Accordingly, the activity of the neuronal populations recorded at specific thalamic locations that correspond to the forepaw and hindpaw circuits was recorded under control conditions and immediately after thoracic SCI. The results demonstrate that peripheral inputs from both extremities overlap on neuronal populations in the somatosensory thalamus.</example>
        <exampleSource>doi: 10.1016/j.nbd.2015.12.003</exampleSource>
        <rdfs:description>The electric response evoked in the CEREBRAL CORTEX by stimulation along AFFERENT PATHWAYS from PERIPHERAL NERVES to CEREBRUM.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SpasticityObservation -->

    <owl:Class rdf:about="http://psink.de/scio/SpasticityObservation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ObservationOfBehaviour"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68009128</descriptionSource>
        <example>Such irritation led to increased hindlimb spasticity in pilot studies beginning after the first full week of injections.</example>
        <exampleSource>doi:10.1038/sj.sc.3102057</exampleSource>
        <rdfs:description>Muscle Spasticity

A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a &quot;free interval&quot;) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SpatialDimensions -->

    <owl:Class rdf:about="http://psink.de/scio/SpatialDimensions"/>
    


    <!-- http://psink.de/scio/SpinalCord -->

    <owl:Class rdf:about="http://psink.de/scio/SpinalCord">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/CentralNervousSystem"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013116</descriptionSource>
        <example>Spinal cord slices with either Oregon green 488 ﬂuores-
cence (see above) or Alexa 488-, respectively Alexa 594-, coupled secondary antibodies were analysed using a Nikon Eclipse TE200 ﬂuorescent microscope.</example>
        <exampleSource>doi:10.1111/j.1460-9568.2009.06929.x</exampleSource>
        <rdfs:description>A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SpinalCordEvokedPotentialsTest -->

    <owl:Class rdf:about="http://psink.de/scio/SpinalCordEvokedPotentialsTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ElectrophysiologyTest"/>
        <example>Indomethacin, an inhibitor of prostaglandin synthesis attenuates alteration in spinal cord evoked potentials and edema formation after trauma to the spinal cord: an experimental study in the rat.</example>
        <exampleSource>PMID: 8450974</exampleSource>
        <rdfs:description>Recording of electrophysiological signals stimulated and recorded in the spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SpinalCordStrapper -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SpinalCordStrapper">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:appliedForInjuryType>Compression</rdfs:appliedForInjuryType>
        <rdfs:introduced>Title: Strapping the spinal cord: an innovative experimental model of CNS injury in rats.
Year: 2008
Species: Rat
DOI: 10.1016/j.jneumeth.2008.01.004</rdfs:introduced>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SpinalFiberTract -->

    <owl:Class rdf:about="http://psink.de/scio/SpinalFiberTract">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <example>Even at this early time-point the RST revealed signiﬁcantly
higher densities in AST animals than under control conditions, and CST axons showed a clear trend towards more prominent in-growth into the secondary than the primary scar ...</example>
        <examplesource>doi:10.1111/j.1460-9568.2009.06929.x</examplesource>
        <rdfs:description>Investigation of specific axonal fibre tracts, e.g. corticospinal tract.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SpringScissors -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SpringScissors">
        <rdf:type rdf:resource="http://psink.de/scio/Scissors"/>
        <rdfs:description>A spinal hook is used to elevate the rat spinal cord before it is cut with fine spring scissors.</rdfs:description>
        <rdfs:videoReference>Jove Title: Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
Jove Doi: 10.3791/53331
Jove Year: 2016
Jove Species: Rat</rdfs:videoReference>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/StaircaseTest -->

    <owl:Class rdf:about="http://psink.de/scio/StaircaseTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorTest"/>
        <rdfs:description>The animal reaches downwards to grasp pellets on a staircase.
Tests for
independent forelimb reaching and grasping, gripping ability.</rdfs:description>
        <rdfs:introduced>Title: The &quot;staircase test&quot;: A measure of independent forelimb reaching and grasping abilities in rats
Year: 1991
Species: Rat
DOI: 10.1016/0165-0270(91)90048-5</rdfs:introduced>
    </owl:Class>
    


    <!-- http://psink.de/scio/StatisticalTest -->

    <owl:Class rdf:about="http://psink.de/scio/StatisticalTest"/>
    


    <!-- http://psink.de/scio/StemCell -->

    <owl:Class rdf:about="http://psink.de/scio/StemCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Cell"/>
    </owl:Class>
    

    <owl:Class rdf:about="http://psink.de/scio/StemCellSourceType"/>


    <!-- http://psink.de/scio/StudyDesign -->

    <owl:Class rdf:about="http://psink.de/scio/StudyDesign"/>


    <!-- http://psink.de/scio/SubcutaneousDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SubcutaneousDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/DeliveryMethod"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007279</descriptionSource>
        <example>Then the animals were injected with urethane (1.5 g/kg, subcutaneously), and cystometric measurements were repeated four times every 1 hr-interval.</example>
        <exampleSource>doi: 10.1002/nau.22549</exampleSource>
        <rdfs:description>Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Substance -->

    <owl:Class rdf:about="http://psink.de/scio/Substance">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Compound"/>
        <rdfs:description>Substance apllied for a treatment. Only a single substance can be annotated at one time.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SurfaceRightingReflexTest -->

    <owl:Class rdf:about="http://psink.de/scio/SurfaceRightingReflexTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MotorReflexTest"/>
        <example>Agmatine-Reduced Collagen Scar Area Accompanied With Surface Righting Reflex Recovery After Complete Transection Spinal Cord Injury</example>
        <examplesource>10.1097/BRS.0b013e318205e3f7</examplesource>
        <rdfs:description>In brief, the mouse was held gently on its back with two fingers holding on either side of the head and two fingers holding the hindquarters of the neck. The mouse was released and the time in seconds for the mice to flip over onto its abdomen with all the four paws touching the surface of the ground was measured.
From: DOI: 10.1097/BRS.0b013e318205e3f7
Tests for movement coordination, muscle strength</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SurgeryTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/SurgeryTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysicalTreatment"/>
        <example>The effect of spinal canal narrowing and the timing of decompression after a spinal cord injury were evaluated using a rat model.</example>
        <exampleSource>PMID: 10472095</exampleSource>
        <rdfs:description>Surgical procedure as treatment for spinal cord injury as e.g. decompression surgery.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SurgicalTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/SurgicalTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ModificationTreatment"/>
        <rdfs:description>Experimental modification of a certain organ to influence outcome after spinal cord injury.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SurvivalObservation -->

    <owl:Class rdf:about="http://psink.de/scio/SurvivalObservation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ObservationOfBehaviour"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013534</descriptionSource>
        <rdfs:description>Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.</rdfs:description>
        <exampleSource>PMID: 10898365</exampleSource>
        <example>All animals survived in group 1. However, the mortality rates in group 2 were 25% and in group 3, 50%, respectively, which mirrors the severity of the trauma.</example>
    </owl:Class>
    


    <!-- http://psink.de/scio/SwimmingTest -->

    <owl:Class rdf:about="http://psink.de/scio/SwimmingTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/LocomotorTest"/>
        <example>Three scorers assessed independently all outcome measures in a blinded fashion. Neurological function was evaluated
24 h after injury and then twice a week (17, 18), as well as by a swimming test (19). In this assessment, a rat was placed in
the center of a round tub of water (40 cm diameter) filled to a depth of 30 cm with a wire mesh ladder attached to the side.</example>
        <exampleSource>doi:  10.1073/pnas.142287899</exampleSource>
        <rdfs:description>Swimming  task for analysis of locomotor activity.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Syringe -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Syringe">
        <rdf:type rdf:resource="http://psink.de/scio/ApplicationInstrument"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013594</descriptionSource>
        <example>Drugs were microinjected into spinal segments T12-L3 through a micropipette attached to a Hamilton microliter syringe.</example>
        <exampleSource>PMID: 9187327</exampleSource>
        <rdfs:description>Instruments used for injecting or withdrawing fluids. (Stedman, 25th ed)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/TShapedLesion -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/TShapedLesion">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>A T-shaped lesion that included the dorsal half of the spi-
nal cord with the main CST as well as the dorsolateral and
ventromedial parts of the CST was made at thoracic level T8
with iridectomy scissors and a sharp, pointed blade (Fig 3C).</example>
        <exampleSource>PMID: 16173073</exampleSource>
        <rdfs:description>(bilateral dorsal hemisection and complete midline transection)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/TailFlickReflexTest -->

    <owl:Class rdf:about="http://psink.de/scio/TailFlickReflexTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PainTest"/>
        <descriptionSource>doi:10.1016/j.surneu.2007.05.056</descriptionSource>
        <example>Of these, the TFR in response to tail pinch was present in 16 (41%) cases.</example>
        <exampleSource>doi:10.1016/j.surneu.2007.05.056</exampleSource>
        <rdfs:description>The TFR in rats is a classic nociceptive test originally described by D&apos;Amour and Smith, in which pinching of the tail or hind leg produces a withdrawal response. The TFR is a general flexor withdrawal reflex that functions in intact as well as in decerebrated rats.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/TailVeinDelivery -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/TailVeinDelivery">
        <rdf:type rdf:resource="http://psink.de/scio/IntravenousDelivery"/>
        <example>To investigate this, we used Schwann cell transplantation via the tail vein, hyperbaric oxygen therapy, or their combination, in rat models of spinal cord contusion injury.</example>
        <exampleSource>doi: 10.4103/1673-5374.165520</exampleSource>
        <rdfs:description>Blood vessel in the animal tail.</rdfs:description>
    </owl:NamedIndividual>
    

    


    <!-- http://psink.de/scio/Temperature -->

    <owl:Class rdf:about="http://psink.de/scio/Temperature">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
        <example>An epidural perfusion device was applied to maintain a steady temperature (18 °C) for 120 min with gradual rewarming to 37 °C</example>
        <exampleSource>PMID: 26322652</exampleSource>
    </owl:Class>
    


    <!-- http://psink.de/scio/TemperatureTreatment -->

    <owl:Class rdf:about="http://psink.de/scio/TemperatureTreatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysicalTreatment"/>
        <example>An epidural perfusion device was applied to maintain a steady temperature (18 °C) for 120 min with gradual rewarming to 37 °C</example>
        <exampleSource>PMID: 26322652</exampleSource>
        <rdfs:description>Induction of body temperature changes or changes of the spinal cord temperature as causative treatment.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ThermalHyperalgesiaTest -->

    <owl:Class rdf:about="http://psink.de/scio/ThermalHyperalgesiaTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PainTest"/>
        <example>Heat hyperalgesia was assessed by thermal stimulation of the animal’s hind paw (Plantar test).</example>
        <exampleSource>DOI: 10.1186/s13287-016-0295-2</exampleSource>
        <rdfs:description>A thermal hyperalgesia test as the Plantar Test measures the abnormal pain reaction to a normally painless therman stimulus.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Thickness -->

    <owl:Class rdf:about="http://psink.de/scio/Thickness">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/TemporalInterval -->

    <owl:Class rdf:about="http://psink.de/scio/TemporalInterval">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2006/time#TemporalEntity"/>
        <rdfs:description>TemporalInterval in any unit (minutes, hours, days etc.).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Tissue -->

    <owl:Class rdf:about="http://psink.de/scio/Tissue">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Compound"/>
        <example>We aimed to investigate whether an innovative growth factor-laden scaffold composed of acellular sciatic nerve (ASN) and brain-derived neurotrophic factor (BDNF) could promote axonal regeneration and functional recovery after spinal cord injury (SCI).</example>
        <exampleSource>doi: 10.1371/journal.pone.0042813</exampleSource>
        <rdfs:description>Implantation of a tissue piece as treatment for spinal cord injury.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/TissueSparingTest -->

    <owl:Class rdf:about="http://psink.de/scio/TissueSparingTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
        <exampleSource>doi:  10.1016/j.expneurol.2007.02.009</exampleSource>
        <example>Pioglitazone treatment increased tissue sparing after SCI.</example>
        <rdfs:description>Histological finding of tissue sparing, which is the opposite test to lesion volume measurement.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ToxicityTest -->

    <owl:Class rdf:about="http://psink.de/scio/ToxicityTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SecondaryDegenerationTest"/>
        <example>In the present study, we demonstrate that reduction of glutamate-mediated exitotoxicity via intraperitoneal administration of INI-0602 in the microenvironment of the injured spinal cord elicited neurobehavioral recovery and extensive suppression of glial scar formation by reducing secondary tissue damage.</example>
        <exampleSource>doi: 10.1089/neu.2013.3223</exampleSource>
        <rdfs:description>Histological finding of toxic processes in the context of secondary degeneration.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/TreadmillTraining -->

    <owl:Class rdf:about="http://psink.de/scio/TreadmillTraining">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/RehabilitativeTraining"/>
        <example>Transformation of nonfunctional spinal circuits into functional states after the loss of brain input</example>
        <examplesource>10.1038/nn.2401</examplesource>
        <rdfs:description>Rehabilitative training, enhancement of recovery</rdfs:description>
        <rdfs:videoReference>Jove title: Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
Jove year: 2014
Jove Species: Rat
Jove DOI: 10.3791/51827</rdfs:videoReference>
    </owl:Class>
    


    <!-- http://psink.de/scio/Treatment -->

    <owl:Class rdf:about="http://psink.de/scio/Treatment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Event"/>
        <rdfs:comment>Aggregation class for treatment properties, like delivery, application timepoint etc.</rdfs:comment>
        <rdfs:comment>Therapy or treatment applied after spinal cord injury oder laminectomy.</rdfs:comment>
    </owl:Class>
    


    <!-- http://psink.de/scio/Trend -->

    <owl:Class rdf:about="http://psink.de/scio/Trend">
        <rdfs:description>The trend of a comparison of the result of an investigative test which can be either increase, decrease, or no change.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/UBCMultimechanismDevice -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/UBCMultimechanismDevice">
        <rdf:type rdf:resource="http://psink.de/scio/DistractorDevices"/>
        <rdfs:appliedForInjuryType>Distraction</rdfs:appliedForInjuryType>
        <rdfs:description>University of British Columbia (UBC) multimechanism device</rdfs:description>
        <rdfs:introduced>Title: Modeling spinal cord contusion, dislocation, and distraction: characterization of vertebral clamps, injury severities, and node of Ranvier deformations.
Year: 2009
Species: Rat
DOI: 10.1016/j.jneumeth.2009.04.007</rdfs:introduced>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/UTADistractor -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/UTADistractor">
        <rdf:type rdf:resource="http://psink.de/scio/DistractorDevices"/>
        <rdfs:comment>University of Texas at Arlington (UTA) distractor</rdfs:comment>
        <rdfs:introduced>Title: Characterization of a novel bidirectional distraction spinal cord injury animal model.
Year: 2011
Species: Rat
DOI: 10.1016/j.jneumeth.2011.02.003</rdfs:introduced>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Unilateral -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Unilateral">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>Using a dissecting microscope under sterile conditions a dorsal C2 laminectomy was performed and only the right anterolateral spinal cord was transected at C2 with a microknife.</example>
        <exampleSource>doi:10.1016/j.expneurol.2015.11.007</exampleSource>
        <rdfs:description>Asymmetric lesion of only one lateral half of the spinal cord.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/UnivOfTriesteImpactor -->

    <owl:Class rdf:about="http://psink.de/scio/UnivOfTriesteImpactor">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/WeightDrop"/>
        <example>An impaction device was developed initially at the University of Trieste (UTS) by modification of a small materials testing unit ..</example>
        <exampleSource>doi: 10.1073/pnas.142287899</exampleSource>
        <rdfs:description>The University of Trieste or UTS impactor device is used to inflict accurate and specific weight drop on the exposed spinal cord.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/UrineVoidingTest -->

    <owl:Class rdf:about="http://psink.de/scio/UrineVoidingTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PhysiologyTest"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68014554</descriptionSource>
        <example>The novel combination treatment allows for remarkably lengthy regeneration of certain subtypes of brainstem and propriospinal axons across the injury site and is followed by markedly improved urinary function.</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.1116-12.2013</exampleSource>
        <rdfs:description>Urination
Discharge of URINE, liquid waste processed by the KIDNEY, from the body.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Vehicle -->

    <owl:Class rdf:about="http://psink.de/scio/Vehicle">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Substance"/>
        <rdfs:description>Buffer vehicle, solution, not an instrument like syringe, which is used to carry a compund like a cell or pharmacon.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Ventral -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Ventral">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryArea"/>
        <example>In this study we have examined the distribution of mRNA for neuregulin 1 (NRG1), ErbB3 and ErbB4-receptor tyrosine kinases after a ventral funiculus lesion in the lumbar spinal cord (VFL).</example>
        <exampleSource>PMID: 11797086</exampleSource>
        <rdfs:description>Lesion of the ventral half of the spinal cord.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/VentralHemisection -->

    <owl:Class rdf:about="http://psink.de/scio/VentralHemisection">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/PartialTransection"/>
        <example>After ventral hemisection, postural control did not recover, whereas after dorsal or lateral hemisection it did.</example>
        <exampleSource>doi: 10.1152/jn.00009.2008</exampleSource>
        <rdfs:description>Partial transection of the spinal cord at the ventral side, leaving the dorsal spinal tracts intact.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Vertebrae -->

    <owl:Class rdf:about="http://psink.de/scio/Vertebrae">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/VertebralLocation"/>
    </owl:Class>
    

    <!-- http://psink.de/scio/VertebralLocation -->

    <owl:Class rdf:about="http://psink.de/scio/VertebralLocation">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Location"/>
        <rdfs:description>Number refers as described in injury height and injury height detail reference.</rdfs:description>
    </owl:Class>
    

    <!-- http://psink.de/scio/VertebralArea -->

    <owl:Class rdf:about="http://psink.de/scio/VertebralArea">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/VertebralLocation"/>
    </owl:Class>
    

    <!-- http://psink.de/scio/VertebralSegment -->

    <owl:Class rdf:about="http://psink.de/scio/VertebralSegment">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/VertebralLocation"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Vibraknife -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Vibraknife">
        <rdf:type rdf:resource="http://psink.de/scio/CuttingDevice"/>
        <example>To study the pathophysiology of spinal cord injury (SCI), we used the LISA-Vibraknife to generate a precise and reproducible dorsal laceration SCI in the mouse.</example>
        <exampleSource>doi: 10.1089/neu.2008.0543</exampleSource>
        <rdfs:appliedForInjuryType>Transection</rdfs:appliedForInjuryType>
        <rdfs:description>Electronic vibrating sharp blade for cutting the spinal cord.</rdfs:description>
        <rdfs:videoReference>Jove DOI: 10.3791/50030
Jove Title: Controlled Cervical Laceration Injury in Mice
Jove Species: Mouse
Jove Year: 2013</rdfs:videoReference>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Virus -->

    <owl:Class rdf:about="http://psink.de/scio/Virus">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Compound"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68014780</descriptionSource>
        <rdfs:description>Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Voltage -->

    <owl:Class rdf:about="http://psink.de/scio/Voltage">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/VoltageApplication -->

    <owl:Class rdf:about="http://psink.de/scio/VoltageApplication">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/ElectromagneticField"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Volume -->

    <owl:Class rdf:about="http://psink.de/scio/Volume">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/WalkingAnalysisTest -->

    <owl:Class rdf:about="http://psink.de/scio/WalkingAnalysisTest">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/LocomotorTest"/>
        <example>Dynamic assessment of foot motion during treadmill walking revealed a significantly decreased external rotation during the entire step cycle after 8 weeks in rolipram-treated animals.</example>
        <exampleSource>doi: 10.1016/j.bbr.2012.12.056</exampleSource>
        <rdfs:description>Analysis of the walking kinematics and kinetics either using a treadmill or another device, or in the open field.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Weight -->

    <owl:Class rdf:about="http://psink.de/scio/Weight">
        <rdfs:subClassOf rdf:resource="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
        <example>After laminectomy, the vertebral column was stabilized with clamps and a 10 g rod was dropped from a 12.5 mm height over the exposed spinal cord and the compression maintained for 5 seconds.</example>
        <exampleSource>PMID: 26896212</exampleSource>
        <rdfs:description>Any weight measured in µg, g or other units.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/WeightDrop -->

    <owl:Class rdf:about="http://psink.de/scio/WeightDrop">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/InjuryDevice"/>
        <rdfs:description>Usually custom made devices for weight drop contusion injuries.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/17BetaEstradiolE2 -->

    <owl:Class rdf:about="http://psink.de/scio/17BetaEstradiolE2">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004958</descriptionSource>
        <rdfs:description>The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.</rdfs:description>
    </owl:Class>
    


    <!-- http://data.nasa.gov/qudt/owl/qudt#Quantity -->

    <owl:Class rdf:about="http://data.nasa.gov/qudt/owl/qudt#Quantity"/>
    


    <!-- http://www.w3.org/2006/time#TemporalEntity -->

    <owl:Class rdf:about="http://www.w3.org/2006/time#TemporalEntity"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Individuals
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://biochem./Celebocid -->

    <owl:NamedIndividual rdf:about="http://biochem./Celebocid">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>PMID: 14588302</descriptionSource>
        <example>Twenty eight rats received 3 mg/kg of celebocid by means of an orogastric tube within 20 minutes after injury, and 28 received vehicle alone.</example>
        <exampleSource>PMID: 14588302</exampleSource>
        <rdfs:description>Celebocid is a well-characterized COX inhibitor with a 10,000-1-fold selectivity for COX-2 [4]. The drug is now widely used for the treatment of inflammatory arthritis and has an excellent safety profile.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/AcetylsalicylicAcid -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/AcetylsalicylicAcid">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68001241</descriptionSource>
        <rdfs:description>Aspirin

The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Adult -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Adult">
        <rdf:type rdf:resource="http://psink.de/scio/AgeCategory"/>
        <example>Spinal cord hemisection at thoracic level Th8 was performed on adult
female Wistar rats (200–230 g, HanTac:WH; Taconic, Denmark)
using a modiﬁcation of a previously published protocol (Klapka et al.,
2005).</example>
        <exampleSource>doi:10.1111/j.1460-9568.2009.06929.x</exampleSource>
        <rdfs:description>The age category &quot;adult&quot; of the experimental subject as defined by the author. The exact age of an adult organism differs between species.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Aged -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Aged">
        <rdf:type rdf:resource="http://psink.de/scio/AgeCategory"/>
        <example>Dorsal spinal cord hemisection, which included
transection of the corticospinal tract with a Scouten wire knife at
thoracic level eight [10] (lesion group), lesion plus the anti-scarring
treatment (AST group) and laminectomy alone (sham group) were
investigated in 36 young (150–220 g; 2-months-old) and 36
geriatric (252–449 g; 22-months-old) female Wistar rats (Han-
Tac:WH; Taconic, Ry, Denmark) at 1, 7 and 35 days postoperation
(dpo) (Fig. 1A).</example>
        <exampleSource>doi:10.1371/journal.pone.0049812</exampleSource>
        <rdfs:description>The age category &quot;aged&quot; or geriatric of the experimental subject as defined by the author. The exact age of an aged organism differs between species.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Allogeneic -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Allogeneic">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundBiologicalRelation"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/AntiCD11dAntibody -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/AntiCD11dAntibody">
        <rdf:type rdf:resource="http://psink.de/scio/Antibody"/>
        <rdfs:description>Antibody recognizing the CD11d cell surface antigen (the integrin ad subunit)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/AntiNG2Antibody -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/AntiNG2Antibody">
        <rdf:type rdf:resource="http://psink.de/scio/Antibody"/>
        <example>In this study, we demonstrate that acute intraspinal injections of NG2-Ab prevented an acute block of conduction by NG2.</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.4702-12.2013</exampleSource>
        <rdfs:description>Neutralizing antibody to NG2, a 
chondroitin sulfate proteoglycan.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/AntiNogoAAntibody -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/AntiNogoAAntibody">
        <rdf:type rdf:resource="http://psink.de/scio/Antibody"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/67403669</descriptionSource>
        <rdfs:description>Antibody to the Nogo protein.
&quot;Nogo protein [Supplementary Concept]
a neurite growth inhibitor restricting the structural plasticity and regeneration of nerve fibers in the adult vertebrate CNS; Nogo-66 refers to the 66-residue extracellular domain; has been sequenced&quot;</rdfs:description>
    </owl:NamedIndividual>
    


      <!-- http://psink.de/scio/AsialoEPO -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/AsialoEPO">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <rdfs:description>asialoerythropoietin (asialoEPO), a nonerythrogenic erythropoietin derivative</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/AtorvastatinAT -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/AtorvastatinAT">
        <rdf:type rdf:resource="http://psink.de/scio/17BetaEstradiolE2"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/2009919</descriptionSource>
        <rdfs:description>A pyrrole and heptanoic acid derivative,HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; AND TRIGLYCERIDES and to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS and prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/AtropineSulfate -->

    <owl:Class rdf:about="http://psink.de/scio/AtropineSulfate">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicationDuringSurgery"/>
        <example>Spinal cord contusion surgeries were performed under pentobarbital (50-70 mg/kg) anesthesia and prophylactic administration of atropine sulfate (0.8 mg/kg).</example>
        <exampleSource>PMID: 17474317</exampleSource>
        <rdfs:description>Atropine is used to stabilize the heart rate during surgery.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Autologous -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Autologous">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundBiologicalRelation"/>
    </owl:NamedIndividual>
    



    <!-- http://psink.de/scio/BALB_C_Mouse -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/BALB_C_Mouse">
        <rdf:type rdf:resource="http://psink.de/scio/MouseSpecies"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/BW755C -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/BW755C">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=bw755c</descriptionSource>
        <rdfs:description>4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine

A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/BladderExpression -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/BladderExpression">
        <rdf:type rdf:resource="http://psink.de/scio/PostSurgeryCondition"/>
        <example>Bladders were manually expressed three times daily until reflex bladder emptying was established.</example>
        <exampleSource>doi:10.1038/70986</exampleSource>
        <rdfs:description>Catheterization or manual expression of the bladder.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/BoneMarrowStemCell -->

    <owl:Class rdf:about="http://psink.de/scio/BoneMarrowStemCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/StemCell"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/C1 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C1">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C2 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C2">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C3 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C3">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C4 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C4">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C5 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C5">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C57_BL6_Mouse -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C57_BL6_Mouse">
        <rdf:type rdf:resource="http://psink.de/scio/MouseSpecies"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C6 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C6">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/C7 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/C7">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/CD1_Mouse -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/CD1_Mouse">
        <rdf:type rdf:resource="http://psink.de/scio/MouseSpecies"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/CD2_Mouse -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/CD2_Mouse">
        <rdf:type rdf:resource="http://psink.de/scio/MouseSpecies"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/CatWalkGaitAnalysisSystem -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/CatWalkGaitAnalysisSystem">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:description>Semi-automated quantitative gait analysis, temporal and spatial correlations, mechanical allodynia</rdfs:description>
        <rdfs:introduced>Title: Automated Quantitative Gait Analysis During Overground Locomotion in the Rat: Its Application to Spinal Cord Contusion and Transection Injuries
Year: 2001
Species: Rat
DOI:10.1089/08977150150502613</rdfs:introduced>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Cervical -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Cervical">
        <rdf:type rdf:resource="http://psink.de/scio/VertebralSegment"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ChinaShenyangSunshinePharmaceuticalCompany -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ChinaShenyangSunshinePharmaceuticalCompany">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <rdfs:description>http://www.3sbio.com/en/</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ChloralHydrate -->

    <owl:Class rdf:about="http://psink.de/scio/ChloralHydrate">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Sedative"/>
        <example>Female Sprague-Dawley rats (200-250 gm) were anesthetized with chloral hydrate( 360m g/kg,i .p.), and a laminectomy
was performed at the T8 vertebral level to expose a 2.8-mm-diameter
circle of dura.</example>
        <exampleSource>PMID: 7965063</exampleSource>
        <rdfs:description>Hypnotic pharmacological drug with sedative and hypnotic effects.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/ChondroitinaseABC -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ChondroitinaseABC">
        <rdf:type rdf:resource="http://psink.de/scio/Enzyme"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=chondroitinase+ABC</descriptionSource>
        <rdfs:description>An enzyme that catalyzes the eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups. (Enzyme Nomenclature, 1992)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/CorticoSpinalTract -->

    <owl:Class rdf:about="http://psink.de/scio/CorticoSpinalTract">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SpinalFiberTract"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/CyclosporineA -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/CyclosporineA">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68016572</descriptionSource>
        <rdfs:description>A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).</rdfs:description>
    </owl:NamedIndividual>
    

    <!-- http://psink.de/scio/CytrexCorporation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/CytrexCorporation">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>http://www.cytrx.com/</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/DMSO -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/DMSO">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004121</descriptionSource>
        <rdfs:description>A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Darbepoetin -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Darbepoetin">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=darbepoetin</descriptionSource>
        <rdfs:description>A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Decrease -->

    <owl:Class rdf:about="http://psink.de/scio/Decrease">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Change"/>
        <example>Systemic PEG treatment increases cell survival and decreases apoptosis.</example>
        <exampleSource>DOI: http://dx.doi.org/10.1097/NEN.0b013e3181a72605</exampleSource>
        <rdfs:description>Decrease of a certain value measured in an experimental setting.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Dedifferentiation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Dedifferentiation">
        <rdf:type rdf:resource="http://psink.de/scio/InVitroExperimentalProcedure"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/DehydroEpiandrosteroneSulfate -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/DehydroEpiandrosteroneSulfate">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=Epiandrosterone+Sulfate</descriptionSource>
        <rdfs:description>androsterone sulfate [Supplementary Concept]
RN given refers to (3alpha,5alpha)-isomer</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/DigiGait -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/DigiGait">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:company>Mouse Specifics, Inc.</rdfs:company>
        <rdfs:description>High performance digitalimaging system for gait analysis in rat and mouse.</rdfs:description>
        <rdfs:weblink>https://mousespecifics.com/wp-content/uploads/2014/12/DigiGait_ProductSpecificicationSheet_Nov2015-.pdf</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Dipyridamol -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Dipyridamol">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004176</descriptionSource>
        <rdfs:description>A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/DorsalHalf -->

    <owl:Class rdf:about="http://psink.de/scio/DorsalHalf">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <example>One week after hemisection of the 2nd cervical segment (C2Hx) a suspension of either embryonic (E14) MB cells, fetal spinal cord cells (FSC), or media only (sham) was delivered to the dorsal C3 spinal cord of adult male rats.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2016.01.017</exampleSource>
        <rdfs:description>Treatment application in the dorsal spinal cord tissue.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/DragonPharmaceuticals -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/DragonPharmaceuticals">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>http://dragon-pharma.com/</descriptionSource>    
</owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Embryonic -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Embryonic">
        <rdf:type rdf:resource="http://psink.de/scio/StemCellSourceType"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Epidural -->

    <owl:Class rdf:about="http://psink.de/scio/Epidural">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intrathecal"/>
        <example>This study aimed at evaluating the effects of epidural stimulation (EpS) over the spinal EUS controlling center (L3) in combination with a serotonergic receptor agonist on EUS relaxation in naive rats and chronic (6-8 wk) T8 SCI rats.</example>
        <exampleSource>http://www.ncbi.nlm.nih.gov/pubmed/25694482</exampleSource>
        <rdfs:description>Injection of a substance or other treatment application  into the epidural space.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Erythropoietin -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Erythropoietin">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004921</descriptionSource>
        <rdfs:description>Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/EstradiolBenzoate -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/EstradiolBenzoate">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68001565</descriptionSource>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004958</descriptionSource>
        <rdfs:description>Benzoates

Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure.</rdfs:description>
        <rdfs:description>Estradiol
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Estrogen -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Estrogen">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004967</descriptionSource>
        <rdfs:description>Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Ethanol -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Ethanol">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68000431</descriptionSource>
        <rdfs:description>A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/EvansBlue -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/EvansBlue">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68005070</descriptionSource>
        <rdfs:description>An azo dye used in blood volume and cardiac output measurement by the dye dilution method. It is very soluble, strongly bound to plasma albumin, and disappears very slowly.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Female -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Female">
        <rdf:type rdf:resource="http://psink.de/scio/Gender"/>
        <example>Spinal cord hemisection at thoracic level Th8 was performed on adult
female Wistar rats (200–230 g, HanTac:WH; Taconic, Denmark)
using a modiﬁcation of a previously published protocol (Klapka et al.,
2005)</example>
        <exampleSource>doi:10.1111/j.1460-9568.2009.06929.x</exampleSource>
        <rdfs:description>A single subject or a group of subjects with the gender &quot;female&quot;.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/FluanisoneMidazolamMixture -->

    <owl:Class rdf:about="http://psink.de/scio/FluanisoneMidazolamMixture">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>The animals were anesthetized with Dormicum [midazolam, 0.6 mg per 100 gm body weight (bw), i.p.; Roche, Basel, Switzerland] and Hypnorm (fentanyl, 0.02 mg per 100 gm bw, i.p.; Janssen-Cilag, Beerse, Belgium).</example>
        <rdfs:description>Typical sedative mixture for anaesthesia induction and maintenance.</rdfs:description>
        <exampleSource>PMID: 11331396</exampleSource>
    </owl:Class>
    


    <!-- http://psink.de/scio/ForelimbFineMotorControlAbility -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ForelimbFineMotorControlAbility">
        <rdf:type rdf:resource="http://psink.de/scio/MotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ForelimbHindlimbCouplingAbility -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ForelimbHindlimbCouplingAbility">
        <rdf:type rdf:resource="http://psink.de/scio/LocomotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/GaitControlAbility -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/GaitControlAbility">
        <rdf:type rdf:resource="http://psink.de/scio/MotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Glycopyrrolate -->

    <owl:Class rdf:about="http://psink.de/scio/Glycopyrrolate">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/MedicationDuringSurgery"/>
        <example>Rats were premedicated
with an anti-cholinergic drug, glycopyrrolate
(0.03 mg/ml, s.c.; Sabex) and a
mixture of medetomidine hydrochloride (0.3
mg/kg, i.p.; Damitor; Novartis Animal Health)
and buprenorphine (0.05 mg/kg, i.p.; Buprenex;
Reckitt Benckiser Pharmaceuticals).</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.2908-11.2012</exampleSource>
        <rdfs:description>Medication to lower secrete production.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GreyMatter -->

    <owl:Class rdf:about="http://psink.de/scio/GreyMatter">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=grey+matter</descriptionSource>
        <example>The results from the diverse measures used (morphological
appearance on sections, immunocytochemistry and western
blotting of neuronal markers) indicate that loss of grey matter
occurs only in the first 24 hours after injury..</example>
        <exampleSource>doi:10.1371/journal.pone.0012021</exampleSource>
        <rdfs:description>Region of CENTRAL NERVOUS SYSTEM that appears darker in color than the other type, WHITE MATTER. It is composed of neuronal CELL BODIES; NEUROPIL; GLIAL CELLS and CAPILLARIES but few MYELINATED NERVE FIBERS.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/GripStrengthMeter -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/GripStrengthMeter">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:comment>Species: Rat, Mouse</rdfs:comment>
        <rdfs:company>TSE Systems</rdfs:company>
        <rdfs:weblink>http://www.tse-systems.com/products/behavior/motor-function/grip-strength.htm</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Halothane -->

    <owl:Class rdf:about="http://psink.de/scio/Halothane">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>Briefly, 38 male Sprague–Dawley rats (275–325 g; Charles River Breeding Laboratories) were anesthetized with 2% halothane in 70% N02/30% O2.</example>
        <exampleSource>doi:10.1016/S0028-3908(00)00005-8</exampleSource>
        <rdfs:description>Liquid which is evaporated as a halogenated ether gas for inhalation anaesthesia.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/HargreavesApparatus -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/HargreavesApparatus">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:comment>Also known as
Plantar Test.

Tests for 
cutaneous hyperalgesia/allodynia with thermal stimulation, 
nociception.</rdfs:comment>
        <rdfs:company>Ugo Basile</rdfs:company>
        <rdfs:weblink>http://www.ugobasile.com/catalogue/product/37370_plantar_test__hargreaves_apparatus_.html</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/HartleyGuineaPig -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/HartleyGuineaPig">
        <rdf:type rdf:resource="http://psink.de/scio/GuineaPigSpecies"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/HeatSensation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/HeatSensation">
        <rdf:type rdf:resource="http://psink.de/scio/SensoryFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/HematoxyLinEosin -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/HematoxyLinEosin">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004801</descriptionSource>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68006416</descriptionSource>
        <rdfs:description>Eosine Yellowish-(YS)
A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.</rdfs:description>
        <rdfs:description>Hematoxylin
A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain in microscopy and in the manufacture of ink.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Housing -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Housing">
        <rdf:type rdf:resource="http://psink.de/scio/KeepingCondition"/>
        <example>To reduce stress from isolation after the operation, the rats were housed in pairs, and the ambient temperature was maintained at 22–25 °C on highly absorbent bedding.</example>
        <exampleSource>doi:10.1016/S0006-8993(02)03717-4</exampleSource>
        <rdfs:description>The housing of the subject e.g. cage size, social groups of animals etc.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Hydration -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Hydration">
        <rdf:type rdf:resource="http://psink.de/scio/KeepingCondition"/>
        <example>All rats were kept in a 12 hr light/dark cycle and received water and food ad libitum.</example>
        <exampleSource>PMID: 11331396</exampleSource>
        <rdfs:description>Any information on procedures or circumstances which influence hydration of the animal like water ad libitum, saline injections, air humidity.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ICI182780 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ICI182780">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=ICI+182%2C780</descriptionSource>
        <rdfs:description>fulvestrant [Supplementary Concept]
structure give in first source; RN given refers to the (7alpha,17beta)-isomer</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ICOSCorporation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ICOSCorporation">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Ibuprofen -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Ibuprofen">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007052</descriptionSource>
        <rdfs:description>A nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Iloprost -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Iloprost">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68016285</descriptionSource>
        <rdfs:description>An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Increase -->

    <owl:Class rdf:about="http://psink.de/scio/Increase">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Change"/>
        <example>The locomotor function of mMS implanted animals was significantly improved versus controls at 2 and 4 weeks (BBB scores 4.2 versus 2.0 at 2 weeks and 6.8 versus 2.8 at 4 weeks in mMS implanted and control animals, respectively, Mann–Whitney Rank Sum Test, p &lt; 0.05).</example>
        <exampleSource>doi:10.1016/j.biomaterials.2013.09.057</exampleSource>
        <rdfs:description>Increase of a certain value measured in an experimental setting.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Indomethacin -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Indomethacin">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007213</descriptionSource>
        <rdfs:description>A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Inosine -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Inosine">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007288</descriptionSource>
        <rdfs:description>A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Isoflurane -->

    <owl:Class rdf:about="http://psink.de/scio/Isoflurane">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>Mice were anesthetized with isoflurane and the spinal cord was exposed at T10.</example>
        <exampleSource>doi:10.1016/S0896-6273(02)01005-X</exampleSource>
        <rdfs:description>Liquid which is evaporated as a halogenated ether gas for inhalation anaesthesia.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/IsotypematchedmAb1B7 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/IsotypematchedmAb1B7">
        <rdf:type rdf:resource="http://psink.de/scio/Antibody"/>
        <rdfs:description>Anti NeuN Antibody</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Ketamine -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Ketamine">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68007649</descriptionSource>
        <rdfs:description>A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/KetamineAsAnaesthetic -->

    <owl:Class rdf:about="http://psink.de/scio/KetamineAsAnaesthetic">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>Female Sprague Dawley adult rats (200-220 g; 6-8 weeks of age) were anesthetized with an intraperitoneal injection of 7.5 mg/kg ketamine (Phoenix Pharmaceutical, St. Joseph, MO) and 60 mg/kg xylazine (Phoenix Pharmaceutical).</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.0311-05.2005</exampleSource>
        <rdfs:description>Substance for pain relief and sedation during anaesthesia.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/L1 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/L1">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/L2 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/L2">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/L3 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/L3">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/L4 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/L4">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/L5 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/L5">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/LesionSite -->

    <owl:Class rdf:about="http://psink.de/scio/LesionSite">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <example>However, AST applied immediately after lesion enhanced the density of axon proﬁles in the resulting secondary ﬁbrous scar region (Fig. 2D–H) for all axon populations analysed (Fig. 3A and B)</example>
        <exampleSource>doi:10.1111/j.1460-9568.2009.06929.x</exampleSource>
        <rdfs:description>Tissue from the spinal cord injury lesion core (possibly including adjacent tissue).</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Lipopolysaccharide -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Lipopolysaccharide">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008070</descriptionSource>
        <rdfs:description>Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/LithiumChloride -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/LithiumChloride">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=Lithium+chloride</descriptionSource>
        <rdfs:description>A salt of lithium that has been used experimentally as an immunomodulator.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/LongEvansRat -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/LongEvansRat">
        <rdf:type rdf:resource="http://psink.de/scio/RatSpecies"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68020318</descriptionSource>
        <example>Twenty-four adult female Long-Evans hooded rats were randomized into four groups, with six animals in each group: two experimental and two control groups.</example>
        <exampleSource>doi: 10.1016/j.spinee.2015.12.007</exampleSource>
        <rdfs:description>An outbred strain of rats developed in 1915 by crossing several Wistar Institute white females with a wild gray male. Inbred strains have been derived from this original outbred strain, including Long-Evans cinnamon rats (RATS, INBRED LEC) and Otsuka-Long-Evans-Tokushima Fatty rats (RATS, INBRED OLETF), which are models for Wilson&apos;s disease and non-insulin dependent diabetes mellitus, respectively.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Lumbar -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Lumbar">
        <rdf:type rdf:resource="http://psink.de/scio/VertebralSegment"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MPSS -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MPSS">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008775</descriptionSource>
        <rdfs:description>methylprednisolone sodium succinate 

&quot;A PREDNISOLONE derivative with similar anti-inflammatory action.&quot;</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Magnesium -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Magnesium">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008274</descriptionSource>
        <rdfs:description>A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MagnesiumSulfate -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MagnesiumSulfate">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008278</descriptionSource>
        <rdfs:description>A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Male -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Male">
        <rdf:type rdf:resource="http://psink.de/scio/Gender"/>
        <example>For the SCI male rats, the percentage having at-level sensitivity to touch post-contusion was significantly reduced (30%; χ2, p &lt; 0.05) for the group receiving the 17-β estradiol treatment.</example>
        <exampleSource>doi:  10.1016/j.neulet.2010.04.053</exampleSource>
        <rdfs:description>A single subject or a group of subjects with the gender &quot;male&quot;.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MeasurementOfDecreasingTemperature -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MeasurementOfDecreasingTemperature">
        <rdf:type rdf:resource="http://psink.de/scio/BodyTemperatureMeasurement"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MeasurementOfIncreasingTemperature -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MeasurementOfIncreasingTemperature">
        <rdf:type rdf:resource="http://psink.de/scio/BodyTemperatureMeasurement"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Melatonin -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Melatonin">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008550</descriptionSource>
        <rdfs:description>A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MesenchymalStemCell -->

    <owl:Class rdf:about="http://psink.de/scio/MesenchymalStemCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/StemCell"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Methanesulfonamide -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Methanesulfonamide">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013449</descriptionSource>
        <rdfs:description>https://www.ncbi.nlm.nih.gov/mesh/67036871

Sulfonamides
A group of compounds that contain the structure SO2NH2.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MethylprednisoloneMP -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MethylprednisoloneMP">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008775</descriptionSource>
        <rdfs:description>A PREDNISOLONE derivative with similar anti-inflammatory action.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Mexiletine -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Mexiletine">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008801</descriptionSource>
        <rdfs:description>Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MildInjury -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MildInjury">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryIntensity"/>
        <example>To assess this, rats received a mild contusive SCI (120 kdyn, Infinite Horizons impactor) at thoracic level 9 (T9), which causes loss of ∼80% of the ascending sensory dorsal column axonal projections to the gracile nucleus.</example>
        <exampleSource>doi: 10.1089/neu.2015.4030</exampleSource>
        <rdfs:description>For classification of the severity of the spinal cord injury, here as mild, the definition by the author is used as stated in the text.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MinocyclineMC -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MinocyclineMC">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68008911</descriptionSource>
        <rdfs:description>A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Mixed -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Mixed">
        <rdf:type rdf:resource="http://psink.de/scio/Gender"/>
        <example>For SCI (female and male) rats, each animal was anesthetized with a mixture of ketamine (80 mg/kg) and xylazine (10mg/kg), injected intraperitonealy.</example>
        <exampleSource>doi:  10.1016/j.neulet.2010.04.053</exampleSource>
        <rdfs:description>A  group of subjects with mixed gender.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ModerateInjury -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/ModerateInjury">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryIntensity"/>
        <example>To determine whether NSAIDs can restrain active RhoA in the lesioned CNS in vivo, we delivered naproxen (50 mg · kg−1 · d−1), ibuprofen (60 mg · kg−1 · d−1) subcutaneously to rats with a moderate contusion spinal cord lesion at T9.</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.4353-06.2007</exampleSource>
        <rdfs:description>For classification of the severity of the spinal cord injury, here as moderate, the definition by the author is used as stated in the text.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/MortalityObservation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MortalityObservation"/>
    


    <!-- http://psink.de/scio/MotoRater -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/MotoRater">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:company>TSE systems</rdfs:company>
        <rdfs:description>Standardized quantitative and objective kinematic evaluation of animal movement types for rats and mice.</rdfs:description>
        <rdfs:weblink>http://www.tse-systems.com/products/behavior/motor-function/motorater.htm</rdfs:weblink>
    </owl:NamedIndividual>
    



    <!-- http://psink.de/scio/NT3Lentivirus -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/NT3Lentivirus">
        <rdf:type rdf:resource="http://psink.de/scio/Lentivirus"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Negative -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Negative">
        <rdf:type rdf:resource="http://psink.de/scio/Judgement"/>
        <example>Testing a 2-fold higher deferasirox dose resulted in toxic side effects.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2013.05.011</exampleSource>
        <rdfs:description>Judgement of the negative quality of the result of a treatment as stated by the author.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/NektarTherapeuticsInc -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/NektarTherapeuticsInc">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>www.nektar.com/</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Neutral -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Neutral">
        <rdf:type rdf:resource="http://psink.de/scio/Judgement"/>
        <example>Thirty minutes after a cord injury at T-12, naloxone was given i.p. in a bolus of 100 mg/kg, followed by a continuous i.p. infusion of 50 mg/kg/hour for 23 hours. Again, no benefit was observed;</example>
        <exampleSource>PMID: 3808240</exampleSource>
        <rdfs:description>Judgement of the quality of the result of a treatment as stated by the author.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/NitrousOxide -->

    <owl:Class rdf:about="http://psink.de/scio/NitrousOxide">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>Briefly, 38 male Sprague–Dawley rats (275–325 g; Charles River Breeding Laboratories) were anesthetized with 2% halothane in 70% N02/30% O2.</example>
        <exampleSource>doi:10.1016/S0028-3908(00)00005-8</exampleSource>
        <rdfs:description>Nitrous oxide or laughing gas, used as anaesthetic.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NoChange -->

    <owl:Class rdf:about="http://psink.de/scio/NoChange">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Trend"/>
        <rdfs:description>No change of a certain value if compared between two experimental settings</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/NovartisMexico -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/NovartisMexico">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>http://www.novartis.com.mx</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/NuclearTransfection -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/NuclearTransfection">
        <rdf:type rdf:resource="http://psink.de/scio/InVitroExperimentalProcedure"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Nutrition -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Nutrition">
        <rdf:type rdf:resource="http://psink.de/scio/KeepingCondition"/>
        <example>All rats were kept in a 12 hr light/dark cycle and received water and food ad libitum.</example>
        <exampleSource>PMID: 11331396</exampleSource>
        <rdfs:description>Feeding of subjects after spinal cord injury.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/OlfactoryEnsheathingGliaCell -->

    <owl:Class rdf:about="http://psink.de/scio/OlfactoryEnsheathingGliaCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/GlialCell"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/OrthoBiotech -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/OrthoBiotech">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>https://www.janssenbiotech.com/company/</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/P188 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/P188">
        <rdf:type rdf:resource="http://psink.de/scio/Poloxamer"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/P4 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/P4">
        <rdf:type rdf:resource="http://psink.de/scio/Poloxamer"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/PBS -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/PBS">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <rdfs:description>Phospate buffered saline solution.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/PEGFITC -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/PEGFITC">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68011092</descriptionSource>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68016650</descriptionSource>
        <rdfs:description>&quot;Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.&quot;</rdfs:description>
        <rdfs:description>Polyethylene glycol coupled to Fluorescein-5-isothiocyanate

&quot;Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.&quot;</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/PfizerMexico -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/PfizerMexico">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>https://www.pfizer.com.mx</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Phenytoine -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Phenytoine">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68010672</descriptionSource>
        <rdfs:description>An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Pioglitazone -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Pioglitazone">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/67060836</descriptionSource>
        <rdfs:description>•5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
structure given in first source; PPAR agonist used for type II diabetes</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/PolyethyleneGlycolPEG -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/PolyethyleneGlycolPEG">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68011092</descriptionSource>
        <rdfs:description>Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Positive -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Positive">
        <rdf:type rdf:resource="http://psink.de/scio/Judgement"/>
        <example>These results suggest that treatment with a very low dose of estrogen has significant therapeutic implications for the improvement of locomotor function in chronic SCI.</example>
        <exampleSource>doi: 10.1111/jnc.13610</exampleSource>
        <rdfs:description>Judgement of the positive quality of the result of a treatment as stated by the author.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/PositiveSignificance -->

    <owl:Class rdf:about="http://psink.de/scio/PositiveSignificance">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Significance"/>
        <example>There were significant differences in FA when compared to the SCI/PPy/I vs SCI group (p &lt; 0.05).</example>
        <exampleSource>doi: 10.1016/j.spinee.2016.02.012</exampleSource>
        <rdfs:description>The result is statistically significant if a statistical test was performed to test a hypothesis and a certain p value was computed.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Pregabalin -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Pregabalin">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=Pregabalin</descriptionSource>
        <rdfs:description>A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Pregnenolone -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Pregnenolone">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68011284</descriptionSource>
        <rdfs:description>A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/PregnenoloneS -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/PregnenoloneS">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <rdfs:description>Pregnenolone sulfate</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Progesterone -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Progesterone">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68011374</descriptionSource>
        <rdfs:description>The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Proliferation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Proliferation">
        <rdf:type rdf:resource="http://psink.de/scio/InVitroExperimentalProcedure"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Purification -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Purification">
        <rdf:type rdf:resource="http://psink.de/scio/InVitroExperimentalProcedure"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RecombinantEPORhEpo -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RecombinantEPORhEpo">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68004921</descriptionSource>
        <rdfs:description>Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RegularWalkingPatternMaintaining -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RegularWalkingPatternMaintaining">
        <rdf:type rdf:resource="http://psink.de/scio/LocomotorFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Riluzole -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Riluzole">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=riluzole</descriptionSource>
        <rdfs:description>A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RingersSolution -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RingersSolution">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/67051865</descriptionSource>
        <rdfs:description>physiological salt solution containing sodium chloride, potassium chloride, calcium chloride, magnesium sulfate, potassium dihydrogen phosphate, sodium bicarbonate &amp; glucose</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RocheMexico -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RocheMexico">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>www.roche.com.mx/</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Rotarod -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Rotarod">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:company>TSE systems</rdfs:company>
        <rdfs:description>The animal walks on a rotating barrel.
Tests for motor coordination, balance, fatigue resistance</rdfs:description>
        <rdfs:videoReference>Jove Title: Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
Jove Year: 2012
Jove Species: Mouse
Jove DOI:10.3791/3936</rdfs:videoReference>
        <rdfs:weblink>http://www.tse-systems.com/products/behavior/motor-function/rotarod.htm</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/RubroSpinalTract -->

    <owl:Class rdf:about="http://psink.de/scio/RubroSpinalTract">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/SpinalFiberTract"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/RunwayScan -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/RunwayScan">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:company>Clever Sys. Inc.</rdfs:company>
        <rdfs:description>Gait analysis software for walkways for rats and mice.</rdfs:description>
        <rdfs:weblink>http://cleversysinc.com/CleverSysInc/wp-content/uploads/2013/02/Datasheet-RunwayScan.pdf</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SC58125 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SC58125">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=sc58125</descriptionSource>
        <rdfs:description>1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole [Supplementary Concept]
a COX-2 inhibitor</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Sacral -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Sacral">
        <rdf:type rdf:resource="http://psink.de/scio/VertebralSegment"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Saline -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Saline">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <rdfs:description>Physiologic salt solution.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SchwannCell -->

    <owl:Class rdf:about="http://psink.de/scio/SchwannCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/GlialCell"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/SevereInjury -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SevereInjury">
        <rdf:type rdf:resource="http://psink.de/scio/InjuryIntensity"/>
        <example>To better model and understand mechanisms associated with chronic pain after SCI, we subjected adult rats to T3 severe compression or complete transection lesions, and examined pain-related behaviors for three months.</example>
        <exampleSource>doi: 10.1016/j.expneurol.2016.01.009</exampleSource>
        <rdfs:description>For classification of the severity of the spinal cord injury, here as severe, the definition by the author is used as stated in the text.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SigmaAldrich -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SigmaAldrich">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>https://www.sigmaaldrich.com/</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/SodiumPentobarbital -->

    <owl:Class rdf:about="http://psink.de/scio/SodiumPentobarbital">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>Rats (275 – 325g) were anesthetized with sodium pentobarbital (67 mg/Kg, I.P.) and a traumatic spinal cord injury was induced by dropping a 10 g weight from 25 mm onto an impounder positioned on the exposed spinal cord at vertebral level T9, producing a moderate injury, as described previously (19,20).</example>
        <exampleSource>doi:  10.1002/jmri.22323</exampleSource>
        <rdfs:description>Short-acting barbiturate.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/SpragueDawleyRat -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/SpragueDawleyRat">
        <rdf:type rdf:resource="http://psink.de/scio/RatSpecies"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68017207</descriptionSource>
        <example>Eighty female Sprague-Dawley rats were randomly divided into 4 groups: sham group, SCI group, SCI + Vehicle (Veh) group, SCI + A-68930 group.</example>
        <exampleSource>doi: 10.1097/BRS.0000000000001287</exampleSource>
        <rdfs:description>A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Steroid -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Steroid">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013256</descriptionSource>
        <rdfs:description>A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Subdural -->

    <owl:Class rdf:about="http://psink.de/scio/Subdural">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <example>In the present study the lower doses of dexamethasone, 0.125-2.0mg, were administered via the subdural infusion for 2 weeks after an epidural balloon crush of the mid-thoracic spinal cord.</example>
        <exampleSource>http://www.ncbi.nlm.nih.gov/pubmed/26851684</exampleSource>
        <rdfs:description>Injection of a substance or other treatment application  below the dura.</rdfs:description>
    </owl:Class>
    



    <!-- http://psink.de/scio/Syngenic -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Syngenic">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundBiologicalRelation"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T1 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T1">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T10 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T10">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T11 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T11">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T12 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T12">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T13 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T13">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T2 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T2">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T3 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T3">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T4 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T4">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T5 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T5">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T6 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T6">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T7 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T7">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T8 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T8">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/T9 -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/T9">
        <rdf:type rdf:resource="http://psink.de/scio/Vertebrae"/>
        <example>The spinal column was then stabilized with angled clamps, held by a stereotaxic frame, fastened to T8 and T10 spinous processes.</example>
        <rdfs:comment>Topological segment of the spinal cord.</rdfs:comment>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/TakedaPharmaceuticalCompany -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/TakedaPharmaceuticalCompany">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundSupplier"/>
        <descriptionSource>betterhealth.takeda.com/</descriptionSource>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Tetracycline -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Tetracycline">
        <rdf:type rdf:resource="http://psink.de/scio/Substance"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013752</descriptionSource>
        <rdfs:description>A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ThiopentalSodium -->

    <owl:Class rdf:about="http://psink.de/scio/ThiopentalSodium">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/Thoracic -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Thoracic">
        <rdf:type rdf:resource="http://psink.de/scio/VertebralSegment"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/TouchSensation -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/TouchSensation">
        <rdf:type rdf:resource="http://psink.de/scio/SensoryFunction"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/TreadScan -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/TreadScan">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:company>Clever Sys. Inc.</rdfs:company>
        <rdfs:description>Gait analysis software for treadmills for rats and mice.</rdfs:description>
        <rdfs:weblink>http://cleversysinc.com/CleverSysInc/wp-content/uploads/2013/02/Datasheet-TreadScan.pdf</rdfs:weblink>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/UmbilicalCordBloodStemCell -->

    <owl:Class rdf:about="http://psink.de/scio/UmbilicalCordBloodStemCell">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/StemCell"/>
    </owl:Class>
    


    <!-- http://psink.de/scio/VegetableOil -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/VegetableOil">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68010938</descriptionSource>
        <rdfs:description>Oils derived from plants or plant products.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/VentralHalf -->

    <owl:Class rdf:about="http://psink.de/scio/VentralHalf">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <example>We provide a detailed protocol for multi-segmental, intraspinal transplantation of NPCs into the cervical spinal cord ventral gray matter of neurodegenerative models such as SOD1(G93A) mice and rats, as well as spinal cord injured rats and mice (11).</example>
        <exampleSource>doi: 10.3791/3069</exampleSource>
        <rdfs:description>Treatment application in the ventral spinal cord tissue.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/VerticalGrid -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/VerticalGrid">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <example>Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia.</example>
        <examplesource>PMID 10719896</examplesource>
        <rdfs:description>Vertical grid the animal has to climb.
Muscle strength is measured.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/VimentinAntiSenseDNA -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/VimentinAntiSenseDNA">
        <rdf:type rdf:resource="http://psink.de/scio/DNA"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68014746</descriptionSource>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68018076</descriptionSource>
        <rdfs:description>Anti-sense cyclic DNA for

Vimentin

An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.</rdfs:description>
        <rdfs:description>DNA, Complementary

Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/VonFreyFilaments -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/VonFreyFilaments">
        <rdf:type rdf:resource="http://psink.de/scio/Apparatus"/>
        <rdfs:description>Plastic filaments with calibrated bending force, used for testing 
mechanical sensitivity, 
allodynia, 
neuropathic pain.
Species: Rat, mouse</rdfs:description>
        <rdfs:videoReference>Jove Title: Measuring Changes in Tactile Sensitivity in the Hind Paw of Mice Using an Electronic von Frey Apparatus
Jove year: 2013
Jove Species: Mouse
Jove DOI: 10.3791/51212</rdfs:videoReference>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Water -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Water">
        <rdf:type rdf:resource="http://psink.de/scio/Vehicle"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68014867</descriptionSource>
        <rdfs:description>A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/WhiteMatter -->

    <owl:Class rdf:about="http://psink.de/scio/WhiteMatter">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Intraspinal"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68066127</descriptionSource>
        <example>MBP staining was quantified by counting MBP immunoreactive myelin rings in a 100 μm × 100 μm area of the same four white matter regions.</example>
        <exampleSource>doi:10.1016/j.neuroscience.2013.12.024</exampleSource>
        <rdfs:description>The region of CENTRAL NERVOUS SYSTEM that appears lighter in color than the other type, GRAY MATTER. It mainly consists of MYELINATED NERVE FIBERS and contains few neuronal cell bodies or DENDRITES.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/WistarRat -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/WistarRat">
        <rdf:type rdf:resource="http://psink.de/scio/RatSpecies"/>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=Wistar+rat</descriptionSource>
        <example>Forty-five female rats were randomly divided into six groups of seven rats each: the intact, sham, control (SCI), Lav 100, Lav 200, and Lav 400 groups.</example>
        <exampleSource>doi: 10.3389/fnins.2016.00025</exampleSource>
        <rdfs:description>A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Xenogeneic -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Xenogeneic">
        <rdf:type rdf:resource="http://psink.de/scio/CompoundBiologicalRelation"/>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/Xylazine -->

    <owl:Class rdf:about="http://psink.de/scio/Xylazine">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Anaesthetic"/>
        <example>Female Sprague Dawley adult rats (200-220 g; 6-8 weeks of age) were anesthetized with an intraperitoneal injection of 7.5 mg/kg ketamine (Phoenix Pharmaceutical, St. Joseph, MO) and 60 mg/kg xylazine (Phoenix Pharmaceutical).</example>
        <exampleSource>doi: 10.1523/JNEUROSCI.0311-05.2005</exampleSource>
        <rdfs:description>Analog of clonidine, an agonist of the adrenergic receptor, used for sedation, muscle relaxation and analgesia.</rdfs:description>
    </owl:Class>
    


    <!-- http://psink.de/scio/Young -->

    <owl:NamedIndividual rdf:about="http://psink.de/scio/Young">
        <rdf:type rdf:resource="http://psink.de/scio/AgeCategory"/>
        <rdfs:description>The age category &quot;young&quot; of the experimental subject as defined by the author. The exact age of a young organism differs between species.</rdfs:description>
    </owl:NamedIndividual>
    


    <!-- http://psink.de/scio/ZeroSignificance -->

    <owl:Class rdf:about="http://psink.de/scio/ZeroSignificance">
        <rdfs:subClassOf rdf:resource="http://psink.de/scio/Significance"/>
        <example>The mortality rates were, respectively, 5.55 % (2/36) and 13.9 % (5/36) in groups C and D, and there was no significant difference between groups C and D (P = 0.214).</example>
        <exampleSource>doi: 10.1186/s13018-016-0369-y</exampleSource>
        <rdfs:description>The result is not statistically significant if a statistical test was performed to test a hypothesis and a certain p value was not reached.</rdfs:description>
    </owl:Class>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotations
    //
    ///////////////////////////////////////////////////////////////////////////////////////
    <rdf:Description rdf:about="http://psink.de/scio/ApoptosisTest">
        <example>In addition, neuronal apoptosis was detected 24 hr after injury followed by a profound increase
in ED1-positive inflammatory infiltrates, glial fibrillary acidic protein (GFAP)-positive reactive astrocytes,
and oligodendrocyte apoptosis by 1 week after SCI relative to control.</example>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68017209</descriptionSource>
        <rdfs:description>Investigation of apoptosis as a part of secondary degeneration.

One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.</rdfs:description>
    </rdf:Description>


    <rdf:Description rdf:about="http://psink.de/scio/AxonalDamageTest">
        <rdfs:description>Investigation of axonal damage as measure for failed neuroprotection.</rdfs:description>
        <example>The effect of MEL on axonal damage was also investigated using antibody specific for dephosphorylated neurofilament protein (dNFP).</example>
        <exampleSource>PMID: 18086148</exampleSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/AxonalRegenerationTest">
        <example>Even after complete chronic transection, the PEG-bridge allowed long-distance axon regeneration through the grafted area and for, at least, 1cm beyond the lesion/graft border.</example>
        <exampleSource>doi: 10.1016/j.nbd.2014.03.018</exampleSource>
        <rdfs:description>Investigation of axonal regeneration as neuronal cell change. Usually stated in the text as &quot;axonal regeneration&quot; or &quot;axonal regrowth&quot;. This is in contrast to axon sparing or axon sprouting which could also stand for the growth of unlesioned axons.</rdfs:description>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/CystVolumeTest">
        <rdfs:description>Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.</rdfs:description>
        <example>After nanoparticle delivery twice into each rat, the visualized syringomyelic cyst volume significantly decreased from 5.71±0.21 mm3 to 3.23±0.364 mm3 and to 1.48±0.722 mm3.</example>
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68003560</descriptionSource>
        <exampleSource>PMID: 26486048</exampleSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/CytrexCorporation">
        <descriptionSource>http://www.cytrx.com/</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/DragonPharmaceuticals">
        <descriptionSource>http://dragon-pharma.com/</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/FluanisoneMidazolamMixture">
        <example>The animals were anesthetized with Dormicum [midazolam, 0.6 mg per 100 gm body weight (bw), i.p.; Roche, Basel, Switzerland] and Hypnorm (fentanyl, 0.02 mg per 100 gm bw, i.p.; Janssen-Cilag, Beerse, Belgium).</example>
        <rdfs:description>Typical sedative mixture for anaesthesia induction and maintenance.</rdfs:description>
        <exampleSource>PMID: 11331396</exampleSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/LesionVolumeTest">
        <rdfs:description>Analysis of the lesion volume in the tissue post-mortem.</rdfs:description>
        <example>Stereological tissue-volume analysis determined that females, more so than males, also exhibited greater volumes of preserved gray and white matter within the injured cord segment as well as more spared ventral white matter area at the center of the lesion.</example>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/NS398">
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=ns-398</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/NektarTherapeuticsInc">
        <descriptionSource>www.nektar.com/</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/NeuronalCellLossTest">
        <rdfs:description>Test for the failure of neuroprotection, here loss of neuronal cells.</rdfs:description>
        <exampleSource>doi:  10.1186/1471-2202-14-146</exampleSource>
        <example>Intraperitoneal treatment with MnTBAP + nitro-L-arginine significantly reduced motoneuron and cell loss and apoptosis in the gray and white matter compared with the vehicle-treated group.</example>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/NeuroprotectionTest">
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/?term=neuroprotection</descriptionSource>
        <example>Cavity areas significantly decreased and the number of ventral motor neurons significantly increased in the Lav 200 and Lav 400 groups.</example>
        <rdfs:description>The physiological processes and techniques used by the body to prevent neuronal injury and degeneration in the central nervous system following acute disorders or as a result of chronic neurodegenerative diseases.</rdfs:description>
        <exampleSource>doi: 10.3389/fnins.2016.00025</exampleSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/NovartisMexico">
        <descriptionSource>http://www.novartis.com.mx</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/OrthoBiotech">
        <descriptionSource>https://www.janssenbiotech.com/company/</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/PfizerMexico">
        <descriptionSource>https://www.pfizer.com.mx</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/RocheMexico">
        <descriptionSource>www.roche.com.mx/</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/SigmaAldrich">
        <descriptionSource>https://www.sigmaaldrich.com/</descriptionSource>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/SurvivalObservation">
        <descriptionSource>https://www.ncbi.nlm.nih.gov/mesh/68013534</descriptionSource>
        <rdfs:description>Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.</rdfs:description>
        <exampleSource>PMID: 10898365</exampleSource>
        <example>All animals survived in group 1. However, the mortality rates in group 2 were 25% and in group 3, 50%, respectively, which mirrors the severity of the trauma.</example>
    </rdf:Description>

    <rdf:Description rdf:about="http://psink.de/scio/TakedaPharmaceuticalCompany">
        <descriptionSource>betterhealth.takeda.com/</descriptionSource>
    </rdf:Description>
    <rdf:Description rdf:about="http://psink.de/scio/TissueSparingTest">
        <exampleSource>doi:  10.1016/j.expneurol.2007.02.009</exampleSource>
        <example>Pioglitazone treatment increased tissue sparing after SCI.</example>
        <rdfs:description>Histological finding of tissue sparing, which is the opposite test to lesion volume measurement.</rdfs:description>
    </rdf:Description>
    -->


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // General axioms
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/ApoptosisTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/NeuroprotectionTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/AxonalDamageTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/AxonalRegenerationTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/AxonalDamageTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/AxonalSproutingTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/AxonalDiebackTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/AxonalRegenerationTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/AxonalDiebackTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/AxonalSproutingTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/CystVolumeTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/TissueSparingTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/LesionVolumeTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/TissueSparingTest"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/MortalityObservation"/>
            <rdf:Description rdf:about="http://psink.de/scio/SurvivalObservation"/>
        </owl:distinctMembers>
    </rdf:Description>
    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDifferent"/>
        <owl:distinctMembers rdf:parseType="Collection">
            <rdf:Description rdf:about="http://psink.de/scio/NeuronalCellLossTest"/>
            <rdf:Description rdf:about="http://psink.de/scio/NeuroprotectionTest"/>
        </owl:distinctMembers>
    </rdf:Description>
</rdf:RDF>



<!-- Generated by the OWL API (version 4.2.6.20160910-2108) https://github.com/owlcs/owlapi -->

